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ABSTRACT 
 
 
The interaction of anesthetic drugs pentobarbital and propofol with HSA has 
been investigated by using UV-absorption, fluorescence spectroscopy, and 
Fourier transform infrared (FTIR) spectroscopy. The binding constants of 
pentobarbital and Propofol have been determined by both UV- absorption, and 
fluorescence spectroscopy. The values of the binding constants calculated at 
293k are 1.812×104 M-1 for pentobarbital and 2.55x103 M-1 for propofol. The 
Stern–Volmer quenching constant values were found to be 3.875 x 107 L.mol-1 
pentobarbital and 9.686x106 L mol-1 propofol. The UV-absorption intensity of 
HSA-drug complexes has increased with increasing of pentobarbital and 
propofol concentration.  
The fluorescence data reveals a decrease in HSA-drug emission intensity with 
the increase of pentobarbital and propofol concentration. This decrease of 
intensity indicates that both of pentobarbital and propofol have a strong ability 
to quench the intrinsic fluorescence of HSA through a static quenching 
mechanism.  
FTIR spectroscopy with Fourier self-deconvolution technique and second 
derivative resolution enhancement, as well as curve-fitting procedures were 
applied in the analysis of the amide I,II, and III regions to determine the effects 
on protein secondary structure and drug binding mechanisms. All peak positions 
in the three amide regions (amid I, amide II and amide III) have been assigned 
and any effects due to concentration changes have been investigated. The FTIR 
spectra measurements indicate a change in the intensity of absorption bands due 
to change in the drug concentrations. In addition, a larger intensity decrease in 
the absorption band of the α-helix relative to that of β-sheets has been observed. 
This variation in intensity is related indirectly to the formation of H-bonding in 
the drug HSA complexes, which accounts for the different intrinsic propensities 
of α-helix and β-sheets in HSA.  
iv 
 
It was found that the (carbonyl groups and N-H groups) and the hydroxyl group 
which are substituted on aromatic ring of pentobarbital and propofol 
respectively play an important role in the protein’s secondary structure changes. 
The analysis supports that propofol with the lower binding constant has a faster 
sedation time than pentobarbital. 
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Chapter one 
 
 
INTRODUCTION 
 
 
1.1 Pentobarbital 
Pentobarbital is a short-acting barbiturate (Fig.1.1) that was first synthesized in 1928 (Donald, 
2003). Pentobarbital was long used as anxiolytic and hypnotic (Whitlock, 1975). Barbiturates 
were substituted pyrimidine derivatives in which the basic structure common to these drugs is 
barbituric acid, a substance which has no central nervous system (CNS) activity, CNS activity 
is attained by substituting alkyl, alkenyl, or any groups on the pyrimidine ring. Barbiturates act 
as central nervous system depressant, and they produce a wide spectrum of effects, from mild 
sedation to anesthesia. Pentobarbital is approved for human uses by the FDA for seizure and 
preoperative sedation. Pentobarbital has a variety of effects, including motor impairments, in 
both humans and animals (Hetzer et al, 1999). Pentobarbital is capable of having a profound 
effect on brain function; it is known to depress cerebral glucose utilization and electrical 
activity(Hodes et al, 1985). 
 
Figure 1.1:  Chemical structure of pentobarbital. 
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1.2 Propofol  
Propofol (2, 6-diisopropylphenol) is an ultra–short-acting, non barbiturate, sedative-hypnotic 
agent (Fig.1.2) (Edward Morgan et al, 1995) with an arm-brain circulation time of 90 to 100 
seconds. It is administered as a bolus for the induction of anesthesia and as an infusion for 
maintenance of anesthesia or for sedation (Bryson et al, 1995). A rapid and complete recovery 
( Mandsager et al, 1995) is a major advantage of this drug, which is attributable to extensive 
biotransformation of the parent compound. It has rapid redistribution and clearance account 
for its brief sedation effect and the need for repeated boluses or continuous infusion to 
maintain the level of anesthesia and sedation (Smith et al, 1994; Fulton et al, 1995; Bryson et 
al, 1995). Propofol induces dose- dependent central nervous system depression (Hannallah et 
al, 1991). Also at subhypnotic doses, propofol induces sedation, amnesia, and antiemetic 
activity (Reves et al, 2000).  
 
The rapid titrability, brief pharmacologic effect, and maintenance of spontaneous ventilation 
make intravenous propofol an ideal agent for deep sedation. It is preferred for the shorter-
duration computed tomography studies (Pershad et al, 2006). This highly lipophylic drug 
crosses promptly the cellular membrane and takes about 2-4 minutes for establishing blood-
brain balance, causing a rapid induction of anesthesia. It is metabolized in liver to form 
glucuronid and sulfate conjugates (Muñoz-Cuevas et al, 2005; Padrid, 2000; Schuttler et al, 
2000). 
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Figure 1.2:  Chemical structure of propofol. 
 
 
1.3 Human serum albumin (HSA) 
HSA is the major circulating plasma protein, which is synthesized in the liver. It is present in 
all body fluids, for example its blood concentration is about 40 mgmL−1 (׽0.6 mmol L−1) 
(Curry et al, 1998). HSA is a single-chain protein containing three albumin domains 
characterized by six disulfide bridges. The three dimensional structure of the entire serum 
albumin has 585 amino acids in complex with fatty acids. For example polyunsaturated 
arachidonic acid was determined by X-ray diffraction (Schaller et al, 2008). HSA consists of 
three homologous domains (labeled as I, II and III), each of which is divided into two 
subdomains, A and B, having six and four α-helices, respectively (Curry et al, 1999). HSA 
exhibits a heart-shaped structure characterized by a high content α-helices and β-strands.  
 
HSA has a good binding capacity for different types of compounds: water, ions (Ca+2 , Na+ , 
K +) and heavy metal ions (Cu+2 , Zn+2 ), fatty acids, hormones, synthetic drugs and many other 
compounds. Because of its high concentration in plasma (35–50 g/l) and its excellent binding 
capacity, HSA is the major transport protein in plasma; it regulates and maintains the colloidal 
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osmotic pressure in blood, which is essential for the distribution of body fluids between 
intravascular compartments and tissues, so helping in the regulation of body temperature. 
Furthermore, HSA is by far the most important protein contributing to the acid/base balance in 
plasma. Its plasma concentration is a marker for good nutrition and longevity and a decline of 
this concentration is a negative acute-phase marker of illness, trauma and infection (Schaller et 
al, 2008).  
The primary function of HSA is to interact with other molecules. This requires the polypeptide 
chain to fold in one phase and unfold in the next phase allowing for additional bonding. The 
importance of serum albumin in anaesthesia derives from its high concentration in the 
circulatory system and from its ability to bind an extraordinarily diverse range of anesthetic 
drugs (Curry et al, 1999). It has been shown that distribution, free concentration, and 
metabolism of various drugs can be significantly altered as a result of their binding to HSA 
(Kragh-Hansen et al, 1981). 
 
The binding properties of albumin depend on the three dimensional structure of its binding 
sites, which are distributed all over the molecule. Strong binding can decrease the 
concentrations of free drugs in the plasma, whereas weak binding can lead to a short lifetime 
or poor distribution. Investigating the interaction of drugs to HSA can elucidate the properties 
of drug–protein complex, as it may provide useful information of the structural features that 
determine the therapeutic effectiveness of drugs. Therefore, it has become an important 
research field in life sciences, chemistry, and clinical medicine (Ruhl et al, 2003; Cui et al, 
2004).  
 
Multiple drug binding sites have been reported for HSA by several researchers (Oettl et al, 
2007; Kragh-Hansen et al, 2002; Sudlow et al, 1975; Shin-ichi et al, 2008; Ulrich et al, 2006; 
Bhattacharya et al, 2000; Simard et al, 2006). The principle regions of ligand binding sites of 
HSA are located in hydrophobic cavities in sub-domains IIA and IIIA, which are 
corresponding to site I and site II, respectively. Site I is dominated by strong hydrophobic 
interaction with most neutral, bulky, heterocyclic compounds, while site II mainly by dipole–
dipole, van der Waals, and/or hydrogen-bonding interactions with many aromatic carboxylic 
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acids. HSA contained a single intrinsic tryptophan residue (Trp 214) in domain IIA and its 
fluorescence is sensitive to the ligands bounded nearby (Krishnakumar et al, 2002; Il'ichev et 
al, 2002). Therefore, it is often used as a probe to investigate the binding properties of drugs 
with HSA.  
 
The modes of binding include complex formation with metal like copper, hydrophobic and 
electrostatic interaction in high affinity binding and covalent binding to different amino acids. 
Several binding sites are distributed over the molecule according to different marker 
molecules (Kragh-Hansen et al, 1990). For fatty acids alone, seven binding sites have been 
described (Simard et al, 2006). For anesthetic drugs several cases reported more than 50% of a 
clinically administered general anesthetic will be bound to serum albumin. 
 
The molecular interactions are often investigated by a spectroscopic technique including 
fluorescence, UV-absorption, circular dichroism (CD), Fourier transform infrared 
spectroscopy (FT-IR), and nuclear magnetic resonance (NMR). These methods have been 
used to study the interaction of small molecule substances and protein and clarify the 
conformational change of protein (Nahar et al, 1997; Filyasova et al, 2001; Bertucci et al, 
1995; Zsila et al, 2003; Jiang et al, 2003), because of  high sensitivity, rapidity and ease of 
implementation (Cui et al, 2004; Cui et al, 2006; Cui and Wang et al, 2006).  
 
In recent years, many researches on the binding of drugs to protein were carried out (He et al, 
2005; Deepa et al, 2005; Kandagal et al, 2006; Zhao et al, 2006; Xie et al, 2005). However, 
none of these investigations have examined in detail the effects of anesthetic drugs 
(pentobarbital and propofol) on HSA binding constants, binding mechanisms, and the effects 
of pentobarbital and propofol on the protein secondary structure.  
In this thesis, chapter two includes the theoretical background to provide the readers with 
latest developments in this research area. In chapter three, the experimental part will describe 
the materials and the spectroscopic techniques which are used to study the interaction between 
HSA and the anesthetic drugs. Chapter four will describe results and discussions of the 
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binding interaction of HSA with the two drugs by several techniques. Finally chapter five will 
include the main conclusions and future work of this research.  
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Chapter Two 
 
Background and Theoretical Considerations 
We begin this chapter with a brief review of using physical techniques such as spectroscopy to 
provide information about the structural conformation of proteins, electromagnetic radiation, 
electromagnetic spectrum and energy levels of the molecule. In section three, information 
about the vibrational motions of a molecule, normal modes and the types of bond vibrations is 
given. Section four explains the theory of infrared spectroscopy. Section five gives 
information about the principles of Fourier transform infrared spectroscopy. Section six and 
section seven discuss the theory of fluorescence and UV-visible spectroscopy, respectively. 
Finally section eight explains the secondary structure of proteins. 
 
2.1 Electromagnetic radiation 
 
Electromagnetic radiations consist of transverse waves of both electric and magnetic fields 
which oscillate in a perpendicular fashion to each other and to the direction of the propagation. 
These waves cover a wide range of wavelengths, from low-energy radio wave to high-energy 
γ-ray radiation as shown in (Fig.2.1), which also indicates the processes that may occur in an 
atom or molecule exposed to the radiation. 
 
When electromagnetic radiation falls on a particular sample, molecular excitations may result, 
when the energy of the radiation corresponds to the separation of two energy levels of the 
molecule. If the energy of the radiation does not correspond to the separation of two energy 
levels, the radiation will be either transmitted or scattered by the sample (Leslie et al, 1993). 
 
The interaction of electromagnetic radiation with matter is more common through the electric 
field component. Therefore the plane of polarization is conventionally taken to be the plane 
containing the direction of electric field of strength E and that of propagation.  
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Figure 2.1: Regions of the electromagnetic spectrum. 
 
A molecule may undergo rotational, vibrational, electronic or ionization processes, as a result 
of increasing energy .Also a molecule may scatter light in a Raman process, and the light 
source for such an experiment is usually in the visible or near-ultraviolet region .When an 
atom has no rotational or vibrational degrees of freedom, it may undergo only an electronic 
transition or ionization (Michael Hollas, 2004). 
 
Let us consider an isolated molecule in space. It has different forms of energy depending on its 
different types of motion and intermolecular interactions. The total energy of a molecule is 
expressed as the sum of the constituent energies, that is, 
Etotal = Etran + Erot + Evib + Eel+ …                      2 
Where Etran is translational energy due to the motion of the molecule as a whole, Erot is 
rotational energy due to the rotation of molecule around the axis passing through the molecule 
center of gravity, Evib is vibrational energy due to the periodic displacement around the 
equilibrium positions of their atoms, and Eel is electronic energy due to the constant motion of 
the electrons that are associated with each atom and bond (Sathyanarayana, 2004). 
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In general, the spectrum gives information about the spacing of energy levels of the molecule, 
which helps to determine the structure of the molecule. In some types of spectroscopy there 
are only a few, well-separated energy levels. In these cases, only a very narrow range of 
wavelengths is absorbed by the molecule which is excited from its lowest energy state to some 
higher energy state, thus giving an absorption line. In many cases, each energy state has a 
number of energy sublevels with a number of  closely spaced wavelengths being absorbed. 
The lines are so close together, therefore they cannot be resolved and the absorption appears as 
a band or a broad peak as shown in (Fig.2.2) (Britlain et al, 1970). 
 
 
Figure 2.2:  Absorption lines and absorption bands. 
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2.2 Historical developments of spectroscopy 
 
Biological materials have been studied by an array of physical techniques, including many 
types of spectroscopy. Vibrational spectroscopy offers many advantages over other 
spectroscopic techniques: First, the accessibility of experiment, specific functional groups 
provide information about the structural conformation of biological molecules. Second, 
vibrational spectroscopic data are obtained in a non-invasive manner, i.e vibrational 
spectroscopy does not require extrinsic probe molecules such as fluorescent probes. Third, 
there is no limit to the size thus high molecular weight biomaterials can be studied. Fourth, the 
molecular movements that are monitored by the vibrational spectroscopic method are atomic 
motions on the picoseconds scale, and provide all the molecular conformation. There is no line 
broadening in the vibrational spectroscopy due to the investigation of biological materials 
(Lehninger, 1975).  
The history of infrared spectroscopy goes back 200 years, when William Herschel discovered 
the infrared region of the electromagnetic spectrum in 1800 (Coblentz, 1951). “Infrared and 
Raman Spectra of Polyatomic Molecules” was the first publication by Gerhard Herzberg in 
1945, and from that date, vibrational spectroscopy became an important research tool 
(Herzberg, 1945).   
 
The knowledge of the infrared spectra of various types of straight, branched, and cyclic 
hydrocarbons helped the Allied Forces in the Second World War. After the war, commercial 
infrared spectrometers became readily available; all these infrared spectra led to the creation 
of the very useful concept of “group frequency” and culminated in many published works. In 
1954, Bellamy published a papers entitled “Infrared Spectra of Complex Molecules” 
(Bellamy, 1954), Norman Jones and Camille Sandorfys published  “The application of 
Infrared and Raman Spectroscopy to the Elucidation of Molecular Structure” in 1956 (Jones et 
al, 1956).Early infrared spectra of biological materials were published in the 1950s.  
 
Proteins are the most numerous and versatile of biomaterials. The vibrational spectroscopy of 
proteins provides information at different levels of structural system: (a) assessment of protein 
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secondary structure from an analysis of the amide bands, and (b) Mechanistic information 
about protein structure and protein ligand bindings at the level of individual functional groups.  
The first use of infrared spectroscopy of the conformational structure of proteins and 
polypeptides was in 1950 by Elliot and Ambrose (Elliott et al, 1950). They suggested that a 
correlation exists between the position of certain bands in the infrared spectra of proteins and 
the conformation or structure of the polypeptide backbone. Sam Krimm and co-workers 
confirmed this correlation by theoretical calculations of the amide normal modes (Krimm et al, 
1986).   
 
In 1970s, Fourier transform infrared instrumentation became widely available in the field of 
biological systems. FTIR is particularly important for protein solutions. It offers not only 
increased accuracy and reproducibility, but also improvement in the achievable signal to noise 
ratios and the ability to perform measurements with strongly absorbing samples. In 1982, 
Heino was the first to learn about Fourier self-deconvolution and other band-narrowing 
procedures (Theophanides, 1984). Heino and Michael started applying this methodology to the 
analysis of the amide bands in proteins (Susi et al, 1983).   
 
2.3 Molecular vibrations 
When the frequencies of infrared light and the frequency of vibration coincide, the infrared 
light is absorbed by a molecular vibration. The vibration frequency and absorption probability 
depend on the strength and polarity of the vibrating bonds, which are also influenced by intra- 
and intermolecular effects (Vladimir et al, 2007). 
The vibrational motions of a molecule can be considered classically, as being a set of balls 
representing the nuclei, of various masses, connected by Hooke’s law springs which are 
representing the various forces acting between the nuclei. As an example of this model 
consider H2O model, which is illustrated in (Fig. 2.3). 
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Figure 2.3:  Classical model (Ball-and-spring model) of H2O. 
 
 
This figure shows that the stronger forces between the bonded O and H atoms are represented 
by strong springs which provide resistance to stretching the bonds. The weaker force between 
the non-bonded hydrogen nuclei is represented by a weaker spring which provides resistance 
to an increase or decrease of the HOH angle (Michael Hollas, 2004). 
 
In general, each atom has three degrees of freedom, corresponding to the motions along any of 
the three Cartesian coordinate axes (x, y, z). Consider  a molecule with N atoms have 3N 
degrees of freedom, three of which represent translational motion in mutually perpendicular 
directions (x, y, and z axes) and three represent rotational motion about the x, y, and z axes. 
The remaining degrees of freedom represent 3N - 6 (3N - 5) vibrations of a nonlinear (linear) 
molecule, and give the number of ways that the atoms in a nonlinear (linear) molecule can 
vibrate (i.e., the number of vibrational modes), the so-called normal modes of vibration. The 
remaining degrees of freedom that produce a net change in the dipole moment may result in an 
IR activity (Peter et al, 2007).  
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2.3.1 Normal modes of vibration 
 
A normal mode of vibration is one in which all the atoms undergo harmonic motion 
(Schermann, 2008). In each normal mode atoms oscillate in-phase and with the same 
frequency, but generally with different amplitudes. In vibrational spectroscopy, the frequency 
has a sensitive dependence on the forces acting on the individual atoms and on their respective 
masses. These forces do not only result from the chemical bonds connecting the individual 
atoms but also include contributions from nonbonding interactions within the molecule and 
with the molecular environment (Siebert et al, 2008). 
 
The form of the normal modes may be obtained from the bond lengths and angles and of the 
bond-stretching and angle-bending force constants, which are a measure of the strengths of the 
various springs in the ball-and-spring model as shown in the (Fig. 2.3).  
 
The normal modes tend to be localized in a particular group of atoms which is called group 
vibrations, when there is a chain of atoms in which the force constant between two of them is 
different from those between other atoms in the chain. A number of group vibration 
wavenumbers for bond-stretching and angle-bending vibrations are listed in (Table 2.1) 
(Davies, 1963). 
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Table 2.1:  Typical bond-stretching and angle-bending group vibration wavenumbers ω 
(Michael Hollas, 2004). 
 
 
Whenever a molecule absorbs infrared light, the absorbed light energy is converted into 
atomic bond vibrations. The atomic bond vibrations are classified as either stretching or 
bending vibrations. Stretching vibrations are categorized as being either symmetrical 
(movement in the same direction) or anti symmetrical (movement in opposite directions). 
Symmetrical stretching requires lower energy than anti-symmetrical stretching.  Bending 
vibrations are classified as scissoring, rocking, twisting, or wagging. The number of stretching 
vibrations is equal to the number of valance bonds that exist in the molecule and the remaining 
vibrations are termed as deformation modes. Each vibration is described in terms of internal 
coordinates which is defined as increments in bond length, bond angle or dihedral angle 
(Sathyanarayana, 2004). 
For example, the non linear triatomic water molecule has three fundamental vibrational modes 
as shown in (Fig. 2.4).The O-H bonds may vibrate in phase with each other to form symmetric 
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stretching vibration, or they may vibrate out of phase to form anti symmetric stretching 
vibration. The H-O-H bond angle can change in a bending vibration (Kalsi, 2004).  
 
 
 
Figure 2.4: Stretching and bending vibrations of H2O molecule (Kalsi, 2004). 
 
 
2.3.2 Normal modes of harmonic oscillator 
 
The vibrations of atoms in a molecule can be treated by using the harmonic oscillator model. 
In each normal mode, the atoms have approximately harmonic displacements from their 
equilibrium positions; all the atoms vibrate at a certain characteristic frequency, νi  for each 
mode, i.  The potential energy, V(r), of a harmonic oscillator as a function of the distance 
between the atoms (r) is represented by the dashed line, and the actual variation of the 
potential energy as a function of the displacement of the atoms from their equilibrium 
positions is represented by solid line, as shown in (Fig. 2.5).  
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Figure 2.5:  Potential energy of a diatomic molecule as a function of the atomic displacement 
during a vibration for a harmonic oscillator (dashed line) and an anharmonic oscillator (solid 
line) (Peter et al, 2007). 
For any mode in which the atoms vibrate with simple harmonic motion (i.e., obeying Hooke’s 
law), the vibrational energy states, Evib is given by the equation,  
 
                            Evib = h. νi (ni+ ½)                                          (3) 
 
where νi is the fundamental frequency of the particular mode, ni the vibrational quantum 
number of the ith mode (ni = 0, 1, 2 . . .), and h is Planck’s constant. The energy difference for 
transitions between the ground state (ni = 0) and the first excited state (ni =1) of most 
vibrational modes corresponds to the energy of radiation in the mid-infrared spectrum (400 to 
4000 cm-1). From (Fig. 2.5), it can be seen that equation 3 is valid only for low values of the 
vibrational quantum number and is not valid when ni is large. In practice, Evib must be 
described using an anharmonic (Morse-type) potential function. This potential energy is given 
to a first approximation by the expression,   
           
                             Evib = h. νi (ni+ ½) + h. νi .xi (ni+ ½) 2          (4) 
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where xi, the anharmonicity constant, is dimensionless and typically has values between -0.001 
and -0.02, depending on the mode. For many normal modes, only a few atoms have large 
displacements and the rest of the molecule is almost stationary. The frequency of such modes 
is characteristic of the specific functional group in which the motion is centered and is 
minimally affected by the nature of the other atoms in the molecule. Thus, the observation of 
spectral features in a certain region of the spectrum is often indicative of a specific chemical 
functional group in the molecule (Peter et al, 2007; Gordon et al, 2005). 
 
2.3.3 Vibrational energy levels and transitions 
 
Consider an N-atom molecule. Its vibrational energy is characterized by a set 3N-6 vibrational 
quantum numbers n1, n2, n3,…n3N-6. The corresponding vibrational level when all the 
vibrational quantum numbers are equal to zero is the ground state vibrational level. Its energy, 
referred to as zero point energy, Eν (0, 0, 0…) is not zero. For a poly atomic molecule, the 
energy level is referred to as a fundamental or a first harmonic level if only one vibrational 
quantum number nk =1 is not zero. Each of their 3N-6 vibrational quantum numbers is 
independently excited from the ground state to the fundamental level. In addition each of these 
represent a fundamental transition giving rise to a normal mode of vibration. 
For 3N-6 vibrations, the total vibrational energy of a polyatomic molecule is written as the 
sum of individual energies (E1 + E2…+ E3N-6), that is 
 
                            (5) 
 
Where ni is vibrational quantum numbers, h is planck’s constant, and νi is normal vibrational 
frequencies.  
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For an N-atom molecule, the zero point energy Eν (0, 0, 0…) is,  
                                       (6) 
The vibrational energy of a polyatomic molecule with inclusion of the anharmonicity 
correction is 
   
(7) 
 
Where G0 is a constant term usually omitted since it is small. The νe are the harmonic 
frequencies ( Gans, 1971; Howarth, 1973; Barrow, 1962; Whiffen, 1972; Chang, 1971). 
 
2.4 Infrared spectroscopy 
 
Spectroscopy is an experimental method which is concerned with the absorption, emission or 
scattering of electromagnetic radiation by atoms or molecules (Michael Hollas, 2004). Also it 
is one of the important experimental techniques which can determine the electronic structure 
of atoms and molecules (Sathyanarayana, 2004). Vibrational spectra were first studied in the 
form of absorption bands in the infrared region, which was discovered, as the first non-visible 
region of the electromagnetic spectrum, by the astronomer Sir William Herschel in 1800 
(Herschel, 1800).  
 
2.4.1 Infrared regions 
 
Infrared (IR) spectroscopy is defined as the absorption measurement of different IR 
frequencies by a sample positioned in the path of an IR beam.  The main goal of IR 
spectroscopic analysis is to determine the chemical functional groups in the sample where 
different functional groups absorb characteristic frequencies of IR radiation, and it is an 
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important and popular tool for structural elucidation and compound identification (Blitz et al, 
1994; Shaw et al, 1993). 
The infrared range of the electromagnetic spectrum is divided into three regions due to their 
location relative to visible spectrum; the near- infrared, mid- infrared, and far- infrared region. 
The near-infrared, approximately 14000-4000 cm-1 (2.5-0.8 µm), lies adjacent to the visible 
region has high energies to excite overtone or harmonic vibrations. The mid-infrared, 
approximately 4000-400 cm-1 (30-2.5 µm), may be used to study the fundamental vibrations 
and associated rotational-vibrational structure. The far-infrared, approximately 400-10 cm-1 
(1000-30 µm), lies adjacent to the microwave region, and has low energy so it may be used for 
rotational spectroscopy (Colthrup et al, 1990). 
 
2.4.2 Infrared absorption process 
 
The infrared absorption process is a quantized process where any molecule absorbs only 
selected frequencies (energies) of the infrared radiation. The absorption of infrared radiation 
corresponds to changes of energy on the order 8 to 40KJ/mole. In this energy range, the 
radiation corresponds to the range encompassing the stretching and bending vibrational 
frequencies of the bands in most organic molecules. In the absorption process, the frequencies 
of infrared radiation that match the natural vibrational frequencies of the molecule are 
absorbed, and the energy absorbed serves to increase the amplitude of the vibrational motions 
of the bonds in the molecule. However, not all the bonds in a molecule absorb the infrared 
energy. Only those bonds which have changes of the dipole moment as a function of time are 
capable of absorbing infrared energy (Nakanishi et al, 1977). Therefore In the infrared 
spectrum the intensity of absorption due to a particular vibration depends on the change of 
dipole moment during the vibration. For example, the stretching vibration of the strongly polar 
C=O bond gives a strong absorption band, whereas that of the C=C bond gives a weak band 
(Duxbury, 1999). 
 
IR absorption is generally presented in the form of a spectrum showing wavelength or 
wavenumber versus transmittance or absorption intensity. The Transmittance, T, is the ratio of 
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radiant power transmitted by the sample (I) to the radiant power incident on the sample (I0). 
Absorbance (A) is the logarithm to the base 10 of the reciprocal of the transmittance (T) as 
shown in the equation, 
               
           A = log10( 1/T) = -log10 T = -log10 T = -log10I/I0                           (8) 
 
The transmittance spectra provide better contrast between intensities of strong and weak bands 
because transmittance ranges from 0 to 100% T whereas absorbance ranges from infinity to 
zero (Blitz et al, 1994). 
 
2.4.3 Infrared spectroscopy and bond properties 
 
The infrared absorption frequency is usually affected by the bond strength and the masses of 
the bonded atoms. Let us consider a simple heteronuclear diatomic molecule (two different 
atoms) as two vibrating masses connected by a spring. When this spring is stretched or 
compressed beyond the equilibrium distance of the bond, the potential energy of the system 
increases. When a bond vibrates, as for any harmonic oscillator, its energy of vibration is 
continuously and periodically changing from kinetic to potential energy.   
 The total energy of the bond is proportional to the frequency of the vibration, as follows 
                                                 osc h.νosc 
                                                                     (9) 
This total energy for a harmonic oscillator is determined by the force constant of the spring 
(K), and the masses (ml and m2) of the two bonded atoms. The natural frequency of vibration 
of a bond is given by the equation, which is derived from Hooke's Law for vibrating springs.  
                                              
                                                                (10) 
 
 
  
23 
 
 
where µ is the reduced mass of the system, is given by 
 
                                   
                                                       (11) 
 
The force constant K varies from one bond to another. The force constants for triple bonds 
are three times those of single bonds, and the force constants for double bonds are 
twice those of single bonds.  From the last two equations, it is shown that the stronger 
bonds have a larger force constant K and vibrate at higher frequencies than the weaker bonds. 
And the bonds between atoms of higher masses (larger µ) vibrate at lower frequencies than 
bonds between atoms of lower masses. In general, bending motions occur at lower energy 
(lower frequency) than the typical stretching motions because the bending force has lower 
value for the bending force constant K. For example, C-H stretching occurs at ~ 3000 cm-1, 
while C-H bending occurs at ~ 1340 cm-1 ( Nakanishi et al, 1977; Bellamy, 1975). 
 
The vibrational motion is quantized, so it must follow the rules of quantum mechanics, and the 
only transitions which are allowed are given by equation 3. From this equation, the lowest 
energy level is E0= ½ h.ν, and the next highest is E1=3/2h.ν. According to the selection rule 
∆n= ±1, only transitions to the next energy level are allowed; therefore molecules will absorb 
an amount of energy equal to (3/2 – ½) h.ν or h.ν.  
 
As the interatomic distance increases, the energy reaches a maximum, for anharmonic 
oscillator, as seen in (Fig. 2.6). Also the energy levels become more closely spaced with 
increasing interatomic distance in the anharmonic oscillator. The allowed transitions, h.ν, 
become smaller in energy. Therefore, overtones (∆n= ±2, ±3) can be lower in energy than 
predicted by the harmonic oscillator theory (Ferraro et al, 1979). 
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Figure 2.6:  Energy curve for an anharmonic oscillator showing the vibrational levels for a 
vibrating bond. The horizontal lines represent the various vibrational energy levels (Ferraro et 
al, 1979).  
 
2.4.4 Infrared spectra 
 
Infrared spectra used for qualitative analysis may be obtained from a pure liquid, the solid, 
embedded in a KBr disk, or a solution using a non-polar solvent. The reason for using non-
polar solvents, because polar solvent may affect both group vibration and band intensities and 
may be involved in hydrogen-bonding with the solute. Each dip in infrared spectrum is called 
peak or band, which represents the absorption of radiation at certain frequency by the sample 
(Herzberg, 1989). 
 
The infrared spectrum has an important use to determine structural information about a 
molecule. The absorptions of each type of bond such as N-H, C-H, O-H, C=O, C-O, C-C, 
C=C, C=N, and so on, occur only in certain small portions of the vibrational infrared region. It 
is known that any absorption in the range 3000 ±150 cm-1 is almost always due to the presence 
of a C - H bond in the molecule; any absorption in the range 1715 ± 100 cm-1 is normally due 
to the presence of a C=O bond (carbonyl group) in the molecule (Herzberg, 1991). 
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2.5 Fourier transform infrared spectroscopy 
 
An Infrared spectrometer which determines the absorption spectrum for a compound come in 
two types: one of them is Fourier transform infrared FTIR instrument that provides spectra of 
compounds in the common range of 4000 to 400 cm-1, and the other is Dispersive infrared 
spectrometer. 
 
2.5.1 Theory of FTIR 
 
Fourier transform Infrared (FTIR) is the most modern infrared spectrometer which has the 
design of the optical pathway produces interference signals, which contain infrared spectral 
information called interferogram. The interferogram (a time domain spectrum displaying 
intensity versus time) is converted by a mathematical operation known as Fourier 
transformation to the final IR spectrum, which is the frequency domain spectrum showing 
intensity versus frequency (Donald, 2001). 
 
The principle of Fourier transform infrared spectroscopy is the simple interference of 
radiations. When two radiation beams with the same amplitude and wavelength λ interfere in 
phase with each other, the interference is constructive and the resultant amplitude will be 
twice as high. If the two beams are out of phase by (1/2) (2n+1) λ, the interference will be 
destructive and the beams will cancel each other. The amplitude at intermediate phase 
differences is given by the following term,  
                           (12) 
Where θ is the path difference (retardation).The amplitude of the interference pattern of two 
beams with different wavelengths is given by the expression, 
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         (13) 
 
The interferogram, which is a plot of the intensity (amplitude) versus path length difference 
(phase) for the interference of two beams is shown in (Fig. 2.7). 
 
 
Figure 2.7:  Typical interferograms for (a) two beams of identical frequency (b) beams of two 
different frequencies, (c) two narrow band radiation sources with constant amplitude and (d) 
two broad band radiation sources with different amplitude. 
 
 In a Fourier transform spectrometer, the time domain plot in which the changes in the radiant 
power ƒ (t) are recorded as a function of time t is converted into a frequency domain spectrum. 
The Fourier transform of the function ƒ (t) and the inverse relation is defined by the two 
equations respectively, 
                                               (14) 
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                                                                                                         (15) 
where ω  is the natural frequency. The above equations are said to form a Fourier transform 
pair (Griffiths et al, 1986). 
 
2.5.2 Intensity 
 
The intensity for an ideal Michelson interferometer I(x) of a monochromatic radiation and a 
poly chromatic radiation which are travelling towards the detector at the optical retardation x 
is given by the given equations, respectively, 
                                 (16) 
                         (17) 
Where  is the wavenumber of the radiation in gas or vacuum in the interferometer 
( ),  is the intensity of the radiation of wavenumber 
 incident on the beam splitter, R is the reflectance of the beam splitter and T is the 
transmittance of the beam splitter as summing beam splitter efficiency to be 100%. 
The interferogram function F(x) which is the varying part of the interferogram is given by the 
equation, 
                (18) 
This equation shows that the intensity I(x) is known for infinitely small increments of 
retardation x and shows that retardation varies from zero to infinity. Since I(x) and  are 
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Fourier transform pairs, the spectral intensities  are obtained through the Fourier 
transform theorem,  
                                    (19) 
The interferogram can’t have infinite length as shown by the above equation (Ferraro et al 
1979), it must be truncated at x= ± X, so the above equation must be modified to                                         
                                         (20) 
 
2.6 Fluorescence spectroscopy 
 
Luminescence is the emission of light from a substance, and occurs from electronically excited 
states. Luminescence is divided into two categories: fluorescence and phosphorescence 
depending on the nature of the excited state. In excited singlet states, the electron in the 
excited orbital is paired (by opposite spin) to the second electron in the ground-state orbital. 
Consequently, return to the ground state is spin allowed and occurs rapidly by emission of a 
photon. The emission rates of fluorescence are typically108 s–1, so that a typical fluorescence 
lifetime (time between excitation and return to the ground state) is near 10 ns (10 x 10–9 s).  
Phosphorescence is the emission of light from triplet excited states, in which the electron in 
the excited orbital has the same spin orientation as the ground-state electron. Transitions to the 
ground state are forbidden and the emission rates are slow (103 to 100 s–1), so that 
phosphorescence lifetimes are typically milliseconds to seconds (Berlman, 1971). 
 
Fig.(2.8) illustrates the processes that occur between the absorption and emission of light. The 
singlet ground, first, and second electronic states are depicted by S0, S1, and S2, respectively. 
At each of these electronic energy levels the fluorophores can exist in a number of vibrational 
energy levels, depicted by 0, 1, 2, etc. The transitions between states are depicted as vertical 
lines to illustrate the instantaneous nature of light absorption (Szudy, 1998).  Also this figure 
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reveals that the energy of the emission is typically less than that of absorption. Fluorescence 
typically occurs at lower energies or longer wavelengths. This phenomenon was first observed 
by Sir.G.G. Stokes in 1852 at the University of Cambridge (Stokes, 1852). 
 
 
 
 
 
 
 
 
 
 
Figure 2.8: One form of a Jablonski diagram (Lakowicz, 2006). 
 
Fluorescence is a phenomenon whereby a material absorbs light of one wavelength and then 
emits it of a longer wavelength (lower energy). The fluorescence lifetime and quantum yield 
are the most important characteristics of a fluorophore. Quantum yield is the number of 
emitted photons relative to the number of absorbed photons. The lifetime determines the time 
available for the fluorophore to interact with or diffuse in its environment, and hence the 
information available from its emission. 
It is clear that fluorescence is the result of an energy process that occurs in a molecule called 
fluorophore. The wavelength in nanometer is determined by the spectral properties of the 
fluorophores. Fluorophores are divided into two main classes: (1) Intrinsic fluorophores are 
those that occur naturally, such as aromatic amino acids. (2) Extrinsic fluorophore are added to 
the sample to provide fluorescence when none exists, or to change the spectral properties of 
the sample. Intrinsic fluorescence protein originates with the aromatic amino acids tryptophan 
(trp), tyrosine (tyr), and phenylalanine (phe) (Fig. 2.9). The tryptophan residues are the 
dominant source of UV absorbance and emission in proteins (Houck et al, 2006). 
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Figure 2.9: Structures of Tryptophan, Tyrosine, and Phenylalanine respectively 
 (Szudy 1998). 
The intensity of fluorescence is decreased by a variety of processes. This decrease in intensity 
is called quenching. Quenching can occur by different mechanisms. Collisional quenching 
occurs when the excited-state fluorophore is deactivated upon contact with other molecule in 
solution, which is called the quencher. The decrease in intensity of collisional quenching is 
described by the well-known Stern-Volmer equation: 
                        (21) 
where Ksv is the Stern-Volmer quenching constant, kq is the bimolecular quenching constant, 
τ0 is the unquenched lifetime, and [Q] is the quencher concentration. The Stern-Volmer 
quenching constant Ksv indicates the sensitivity of the fluorophore to a quencher. A 
fluorophore buried in a macromolecule like a protein is usually inaccessible to water soluble 
quenchers, so that the value of Ksv is low. Larger values of Ksv are found if the fluorophore is 
free in solution or on the surface of a biomolecule. Fluorescence quenching can occur by a 
variety of other processes. Fluorophores can form nonfluorescent complexes with quenchers. 
This process is referred to as static quenching since it occurs in the ground state and does not 
rely on diffusion or molecular collisions. Quenching can also occur by a variety of trivial, i.e., 
non-molecular mechanisms, such as attenuation of the incident light by the fluorophore itself 
or other absorbing species (Lakowicz, 1991). 
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2.7  UV- visible spectroscopy 
The Ultraviolet (UV) and visible radiation comprise only a small part of the electromagnetic 
spectrum, which includes such other forms of radiation as radio, infrared (IR), cosmic, and X 
rays (Owen, 2000). 
In UV-Vis spectroscopy, the low-wavelength UV light has the highest energy. The interaction 
of UV or visible light with matter exhibits electronic excitation in the molecule. Any change in 
the electron energy level involves a corresponding change in the energy of the molecule. This 
change in energy is called a transition. In general molecules and atoms exist in the ground 
state at room temperature. The transition consists of the excitation of the electron from an 
occupied molecular level (non-bonding p, or bonding π-orbital) to the higher energy orbital 
(anti-bonding, π* or σ*), the promotion of an electron from π-bonding orbital to an anti 
bonding orbital (π*) is denoted (π → π*). The transition (n→ π*) requires less energy 
compared to π → π* or σ→ σ* transition as shown in (Fig. 2.10) (Clark et al, 1993).   
 
 
Figure 2.10: Electronic energy levels. 
 
The absorption spectra are characterized by their shape, maximum wavelength and the peak 
height or molar extinction coefficient. However, the position of the absorbance maximum is 
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not fixed but depends partially on the molecular environment of the chromophore (molecular 
group usually containing a π bond) and on the solvent in which the sample may be dissolved. 
Other parameters, such as pH and temperature, also may cause changes in both the intensity 
and the wavelength of the absorbance maxima. 
 
UV-visible absorption spectroscopy played an important role in studies of protein structure 
and functions. The application of ultraviolet spectroscopy in protein studying was provided by 
Wetlaufer in 1962 (Wetlaufer, 1962), which remains a valuable source of information about 
the technique.    Proteins are colorless to the human eye and show their spectral characteristics 
when viewed in the UV range. UV spectra of proteins result largely from the presence of the 
aromatic amino acids tryptophan, tyrosine, and phenylalanine. The absorbance at short 
wavelength (< 240 nm) is due to peptide amide. A protein at room temperature has a specific 
tertiary structure or conformation that in turn creates a specific electronic environment for the 
aromatic amino acids. If the protein is heated it will, at a certain temperature, unfold or melt 
and lose its structure. In this process, the electronic environment of the aromatic amino acids 
changes, which in turn results in spectral changes or shifts (Robinson et al, 2005). 
 
2.8 Protein structure 
 
The first structures of proteins at an atomic resolution were determined in the late 1950’s 
(Kendrew et al, 1958). Proteins are a particular type of biological molecules that can be found 
in every living o on Earth. Also proteins are linear biological polymers for which the 
monomeric units are amino acids as shown in (Fig. 2.11).Twenty different amino acids are 
used to make proteins, each distinguished by the identity of the “R” group. The amino acids 
are linked to form a polymer by linking the amino group on one amino acid with the 
carboxylic group on another amino acid to form an amide bond(also it is called peptide bond). 
When many amino acids are linked together by an amide bond, they formed a polypeptide, 
which consists of a backbone and sidechains. The backbone of polypeptide comprises the 
amide nitrogen, the alpha carbon and the carbonyl carbon that are contributed by each amino 
acid unit. The sidechains of polypeptide comprise the “R” groups (Byler et al, 1986). 
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Figure 2.11: The structure of an amino acid; the basic building block for making proteins.  
 
The number of amino acids residues they contain in the protein and the identity and sequential 
order of the amino acids are used to distinguish proteins from one another (Surewicz et al, 
1988). 
 
2.8.1 Structure levels of proteins 
 
Protein exhibits four levels of structure: primary, secondary, tertiary and quaternary structure. 
Primary structure of protein is the sequence of amino acids; Secondary structure is highly 
regular sub-structures that describe the local conformation of the amino acids in the protein 
chain. It is stabilized by hydrogen bonds between the amino-groups which carry a partial 
positive charge and keto-groups of the peptide bonds which carry a partial negative charge as 
shown in the (Fig. 2.12). Each hydrogen bond has only relatively small bond energy, but the 
sum of the bond energies over all hydrogen bonds in a protein is considerable. Tertiary 
structure describes the way in which the elements of protein  secondary structure are arranged 
in space and Quaternary structure describes how several polypeptide chains come together to 
form a single functional protein. 
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Figure2.12:  Hydrogen bonding in α-helix (left) and β-sheets (right). In α-helix all hydrogen 
bonds between keto groups and amino groups in the protein backbone occur between 
neighboring amino acids of the same helix. In β-sheets all such hydrogen bonds occur between 
amino acids in different strands, alternating between the right and left neighbor. 
 
2.8.2 Protein structural motives 
 
The secondary structure of proteins includes four particularly common structural motives: first 
α-helix, where the polypeptide backbone is coiled in a right-handed helix and the hydrogen 
bonding occurs between successive turns of the helix. Second β-sheets, the strands of 
polypeptide are stretched out and lay either parallel (all carboxy-terminal ends are at the same 
side) or antiparallel to one another, where the hydrogen bonds form between the strands. α- 
helices and β-sheets are periodic structures allow the amides to hydrogen bond very efficiently 
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with one another. The other elements of secondary structure include β-turns and unordered 
structure. β-turns are sharp turns which connect the adjacent strands in an antiparallel β-sheet. 
The unordered structure is generally loops which form near the surface of proteins and join the 
other elements of secondary structure, also these areas have an important function, because 
they add flexibility to the protein and allow for conformational changes (Surewicz et al, 1988; 
Richardson 1981). 
 
In our work we aim to study and analyze the binding properties between pentobarbital or 
propofol and HSA including binding mechanism, binding constant, and the main sorts of 
binding force at 293 K by using fluorescence spectroscopy, and UV-absorption spectroscopy. 
Another goal of this work was to check the effect of pentobarbital and propofol on HSA 
secondary structure changes using FTIR spectroscopy. 
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Chapter Three 
 
 
Experimental Part 
 
This chapter contains three sections. In the first section, information about the samples and 
their preparation for experiments is given. The second section describes briefly the UV-VIS 
spectrophotometer (NanoDrop ND-1000), Fluorospectrometer (NanoDrop
 
3300), and Bruker 
IFS 66/S spectrophotometer that are used in my study. And the third section deals with the 
experimental procedures which used in this work.  
 
3.1 Materials and sample preparations 
 
Human serum albumin (HSA) (fatty acid free), was used without further purification. Its 
molecular weight is 66.5 KDa. 4 % (wt/v), pentobarbital with a chemical formula 
(C11H18N2O3) and a molecular weight 226.3 g.mol-1, propofol (2, 6-Diisopropylphenol) with a 
chemical formula (C12H18O) and a molecular weight 178.3 g.mol-1, and phosphate buffer 
saline is used to prepare the sample. All above chemicals were purchased from Sigma Aldrich 
Co. Optical grade silicon windows (NICODOM Ltd) are used as spectroscopic cell windows. 
The optical transmission is high with little or no distortion of the transmitted signal. The 100% 
line of a NICODOM silicon window shows that the silicon bands in the MIR region do not 
exhibit total absorption and can be easily subtracted. These windows were purchased from 
Sigma Aldrich Company. 
 
The measurements were carried out using several samples in the form of thin films of HSA, 
pentobarbital mixed with HSA, and propofol mixed with HSA.  
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3.1.1  Phosphate buffer saline solution 
 Phosphate buffer saline was directly prepared by dissolving one foil pouch in one liter double 
distilled water.  
 
Human serum albumin stock solution 
Human serum albumin was dissolved in phosphate buffer saline (pH=7.4) at (80 mg/ml). 
 
3.1.2 Pentobarbital stock solutions 
The molar concentration of stock pentobarbital solution is 0.265M. The desired concentrations 
acheived by using the molarity dilution equation (MiVi=MfVf). The follwowing concentrations 
of pentobarbital (0.96, 0.48, 0.24,0.12, 0.06, 0.03, and 0.015 mM) were prepared in phosphate 
buffer solution (pH=7.4). 
 
3.1.3 Propofol stock solutions  
The density of propofol is 962 gL-1, and  the molecular weight is 178.28 g.mol-1 , by dividing 
the density over the molecular weight; a molarity of (5.396 mol.g-1 = 5.396 M)  is  obtained. 
Different concentrations of propofol (1.92, 1.44, 0.96, 0.48, and 0.24 mM) were prepared in 
phosphate buffer solution(pH=7.4) by using the molarity dilution equation. 
 
3.1.4 HSA-pentobarbital solutions 
The final concentration of HSA-drug solutions were prepared  by mixing equal volume of 
protein and pentobarbital solution. HSA concentration in all samples is 40mg/ml. However, 
the concentration of pentobarbital in the final protein drug solutions is 0.48, 0.24, 0.12, 0.06, 
0.03, 0.015, and 0.0075 mM. 
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3.1.6 HSA-propofol solutions 
The final concentration of HSA-drug solutions were prepared  by mixing equal volume of 
protein and propofol solution. HSA concentration in all samples is 40mg/ml. However, the 
concentration of propofol in the final protein drug solutions is 1.92, 1.44, 0.96, 0.48, and 0.24 
mM.   
 
3.1.7 Thin film preparations 
50 µL of each sample were applied on silicon window.Then evaporated to complete dryness 
over night before measurements. 
 
3.2 Instruments 
The following instruments have been used in taking the required measurements. 
 
3.2.1 UV-VIS spectrophotometer 
UV-VIS spectrophotometer (NanoDrop ND-1000) is used to measure the spectrum of the 
samples in the range between 220-750nm, with 
high accuracy and reproducibility. 1-2 µL 
samples are sufficient to ensure accurate and 
reproducible results when measuring the                                                                                             
sample solutions. It is critical that the liquid 
column be formed so that the gap between the 
upper and lower measurement pedestals is 
bridged with sample, and the light path is 
completely covered by the sample. ND-1000 has 
the capability to measure highly concentrated 
samples without dilution. The excitation is done on 210 nm and the emission occurs at 280nm.  
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3.2.2 Fluorospectrometer 
 
Fluorospectrometer (NanoDrop
 
3300) is used to 
study fluorescent measurements. The uniquely 
clean optics of the retention system (surface 
tension), combined with proprietary signal 
processing for the White LED applications, 
enables measurements across a wide range of 
wavelengths using sample volumes of 1–2 µL 
without cuvettes and costly filter changes. The 
excitation source comes from one of three solid-
state light emitting diodes (LED’s), which are 
oriented 90° to the detector. The excitation source options include: UV LED with maximum 
excitation 365 nm, blue LED with excitation 470nm, and white LED from 500-650 nm 
excitation.  A 2048-element CCD array detector covering 400 – 750 nm is connected by an 
optical fiber to the optical measurement surface. The excitation is done at the wavelength of 
360 nm and the maximum emission wavelength is at 443 nm. The spectrometer is configured 
with a cut filter to eliminate light transmission below 395 nm. The image below lists some of 
common fluorophores that can be measured using the NanoDrop 3300 along with the most 
appropriate excitation LED. 
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3.2.3 Fourier Transform Infrared Spectroscopy 
 
The FTIR measurements were obtained on a Bruker IFS 66/S spectrophotometer equipped 
with a liquid nitrogen-cooled MCT detector and a KBr beam splitter. The spectrometer was 
continuously purged with dry air during the measurements.  
 
There are three basic spectrometer components in an FT system: radiation source (Infrared 
radiation), interferometer (Michelson interferometer), and detector. The Michelson 
interferometer, which produces interference signals, that contain infrared spectral information 
generated after passing through a sample, and measured as a function of optical path 
difference by a detector, consists of three active components  fixed mirror, moving mirror, and 
a beamsplitter as shown in  (Fig. 3.1). The two mirrors are perpendicular to each other, and the 
beamsplitter is a semi reflecting device which is often made by depositing a thin film of 
germanium onto a flat KBr substrate. 
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Figure3.1:  Optical layout of Michelson interferometer in Fourier transforms infrared 
spectrometer. 
 
Radiation from the broadband infrared source is collimated and directed into the 
interferometer, and impinges on the beamsplitter. Half of the infrared beam is transmitted to 
the fixed mirror and the remaining half is reflected to the moving mirror, at the beamsplitter. 
Then the reflected beams from the two mirrors are recombined at the beamsplitter. An 
interference pattern (interferogram) is generated due to changes in the relative position of the 
moving mirror to the fixed mirror. The resulting beam then passes through the sample and is 
eventually focused on the detector. The interferogram contains information over the entire 
Infrared region to which the detector is responsive. Finally a mathematical operation known as 
Fourier transformation converts the interferogram (The time domain spectrum displaying 
intensity versus time within the mirror scan) to the final Infrared spectrum, which is the 
frequency domain spectrum showing intensity versus frequency. The two most popular 
detectors for a FTIR spectrometer are deuterated triglycine sulfate (DTGS) which is 
pyroelectric detector that delivers rapid responses because it measures the changes in 
temperature rather than the value of temperature, and mercury cadmium telluride (MCT) 
which is a photon (or quantum) detector that depends on the quantum nature of radiation and 
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also exhibits very fast responses. Whereas DTGS detectors operate at room temperature, MCT 
detectors must be maintained at liquid nitrogen temperature (77 °K) to be effective.  
Other equipment such as Digital balance, pH meter, vortex, plate stirr, and micropipettes were 
used. Volumetric flasks, beakers, test tubes, petrideshes, and apendroffes  were used in sample 
preparations. 
 
3.2 Experimental procedures 
 
3.3.1 UV-VIS Spectrophotometer procedure 
 
A 1 µL sample is pipetted onto the end of a fiber optic cable (the receiving fiber). A second 
fiber optic cable (the source fiber) is then brought into contact with the liquid sample causing 
the liquid to bridge the gap between the fiber optic ends. The gap is controlled to a 1mm path. 
A pulsed xenon flash lamp provides the light source and a spectrometer utilizing a linear CCD 
array is used to analyze the light after passing through the sample. The instrument is controlled 
by special software run from a PC, and the data is logged in an archive file on the PC.  
The main steps of measuring samples are: 
1. Open the sampling arm and, a small 
quantity (1 µL) of the sample solution 
was pipetted onto the lower measurement 
pedestal. 
 
 
2. Close the sampling arm and 1initiate a 
spectral measurement using the operating 
software on the PC. The sample column 
is automatically drawn between the upper 
and lower measurement pedestals and the 
spectral measurement made. 
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3. When the measurement is complete, 
open the sampling arm and wipe the 
sample from both the upper and lower 
pedestals using a soft laboratory wipe. 
 
 
 
Upon completion of each sample measurement, wiping the sample from the upper and lower 
pedestals is sufficient to prevent sample carryover and avoid residue build up. However, after 
measuring a large number of samples, it may be necessary to clean the areas around the upper 
and lower pedestals thoroughly. It is best to use a precision pipettor (0-2 µL) with precision 
tips to assure that sufficient sample (1-2 µL) is used.  
The A280 method is applicable to purified proteins exhibiting absorbance at 280nm. This 
module displays the UV spectrum, measures the protein’s absorbance at 280 nm (A280) and 
calculates the concentration (mg/ml).  
When the NanoDrop
 
ND-1000 spectrophotometer is blanked, a spectrum is taken of a 
reference material (blank) and stored in memory as an array of light intensities by wavelength. 
When a measurement of a sample is taken, the intensity of light that has transmitted through 
the sample is recorded. The sample intensities along with the blank intensities are used to 
calculate the sample absorbance according to the following equation: 
Absorbance = -log (Intensitysample / Intensityblank) 
 
Thus, the measured light intensity of both the sample and of the blank are required to calculate 
the absorbance at a given wavelength. 
 
The Beer-Lambert equation is used to correlate the calculated absorbance with concentration: 
A= ε.b.L where A is the absorbance represented in absorbance units (A), ε is the molar 
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absorptivity coefficient (or extinction coefficient) with units of Lmol-1cm-1, b is the path 
length in cm, and L is the sample concentration in moles/liter or molarity (M).  
 
3.3.2 Fluorospectrometer procedure 
 
A 1-2 µL sample is pipetted onto the end of the lower measurement pedestal (the receiving 
fiber). A non-reflective “bushing” attached to the arm is then brought into contact with the 
liquid sample causing the liquid to bridge the gap between it and the receiving fiber. The gap, 
or pathlength, is controlled to 1mm. Following excitation with one of the three LEDs, emitted 
light from the sample passing through the receiving fiber is captured by the spectrometer. The 
NanoDrop 3300 is controlled by software run from a PC.  
The main steps for making a measurement are:  
 
1. Open the sampling arm and a small 
quantity (1 µL) of the sample solution was 
pipetted onto the lower measurement 
pedestal. 
 
 
 
 
 
2. Close the sampling arm and initiate a 
measurement using the operating software 
on the PC. The sample column is 
automatically drawn between the upper 
bushing and the lower measurement 
pedestal and the measurement is made.  
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3. When the measurement is complete, open 
the sampling arm and blot the sample from 
both the upper bushing and the lower 
pedestal using low lint laboratory wipe. 
 
 
Blotting the sample from the upper bushing and lower pedestal upon completion of each 
sample measurement is usually sufficient to prevent sample carryover and avoid residue 
buildup. Although generally, 2 µl water aliquots can be used to clean the measurement 
surfaces to ensure no residual sample is retained on either the pedestal or the bushing. 
 
3.3.3 Fourier transform infrared spectroscopy procedure 
The absorption spectra for silicon window alone, phosphate buffer saline, free HSA, 
pentobarbital, and propofol on silicon window in the wave number range of 4000 – 400 cm-1 
are obtained as background spectra and these spectra are shown in (Figures 3.2-3.6).   
Each spectrum is taken as an average of 60 scans to increase the signal to noise ratio, and the 
spectral resolution was at 4 cm-1. The aperture used in this study was 8 mm, since we found 
that this aperture gives best signal to noise ratio. Baseline correction, normalization and peak 
areas calculations were performed for all the spectra by OPUS software (optics user software). 
The peak positions were determined using the second derivative of the spectra.  
The infrared spectra of HSA, pentobarbital–HSA complex, and propofol-HSA complex   were 
obtained in the region of 1800–1000 cm−1. The FTIR spectrum of free HSA was acquired by 
subtracting the absorption spectrum of the buffer solution from the spectrum of the protein 
solution. For the net interaction effect, the difference spectra {(protein and 
pentobarbital/propofol solution) – (protein solution)} were generated using the featureless 
region of the protein solution 1800-2200 cm–1 as an internal standard (Surewicz et al, 1993).  
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Figure 3.2: FTIR spectra of silicon window in the region of 4000-400 cm-1. 
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Figure 3.3:  FTIR spectra of phosphate buffer saline in the region of 4000-400cm-1. 
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Figure 3.4:  FTIR spectra of free HSA in the region of 4000-400cm-1. 
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Figure 3.5:  FTIR spectra of pentobarbital in the region of 4000-400cm-1. 
 
 
 
 
 
 
 
 
  
51 
 
 
Figure 3.6:  FTIR spectra of propofol in the region of 4000-400cm-1. 
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3.3.3.1 FTIR data processing tasks 
  
The advantage of an FTIR instrument is that high speed and sensitivity, where it acquires the 
interferogram in less than a second. Modern FTIR spectrometers are usually equipped with a 
powerful, computerized data system. It can perform a wide variety of data processing tasks 
such as Fourier transformation, spectral subtraction, baseline correction, smoothing, 
integration, curve fitting, Fourier self- deconvolution and library searching (Bell, 1972). 
 
In our study several tasks are used to analyze data: 
 
1. Baseline correction 
 
The offset correction is performed by selecting a single point of multiple points on a spectrum 
and adding or subtracting a y value (intensity value) from the point or points to correct the 
baseline offset. This preprocessing step is used to align the baseline of two or more spectra 
causing them to overlap, or it is used to bring the minimum point to zero. 
 
2. Derivatives 
 
Derivatives are used to remove offset and slope due to background differences. In our study 
the second derivative is used for FTIR spectrum for free HSA, and the spectra for HSA with 
different concentrations of drugs (Workman, 1998). 
 
 
3. Fourier self- deconvolution 
Fourier self-deconvolution is the most widely used band narrowing technique in infrared 
spectroscopy of biological materials (Kauppinnen et al, 1981). The goal of Fourier self-
deconvolution is to enhance the apparent resolution of a spectrum, or to decrease the line 
width. Spectral ranges comprising broad and overlapping lines can thus be separated into 
sharp single lines.  
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In general, the deconvolution corresponds to a multiplication of the interferogram I(x) using 
the exp (a*x) deconvolution function for lorentzian and exp (a*x*x) for gaussian shapes, 
which intensifies the interferogram edges. The deconvolution factor is the maximum value of 
these functions at the end of the interferogram. Deconvolution factors of 100, 1000 and 5000 
correspond to a maximum amplification of 3.4, 12.8, and 40 in case of lorentzian shapes, and 
1.06, 3.2 and 16 in case of gaussian shapes. If you work with Lorentzian shapes it is 
recommended to increase the deconvolution factor in the order 50, 100, 1000, 5000, and to 
stop if the resultant spectrum shows artificial oscillations (BRUKER, 2004). Successful 
application of Fourier self deconvolution to overlapping absorption bands can significantly 
enhance peak separation. The application of deconvolution to the amide I, amide II, amide III 
regions of proteins reveals the existence of considerable fine structure for most proteins 
(Workman, 1998). 
 
4. Curve fitting 
The curve fitting command allows calculating single components in a system of overlapping 
bands. A model consisting of an estimated number of bands and a baseline should be 
generated before the fitting calculation is started. The model can be set up interactively on the 
display and is optimized during the calculation (BRUKER, 2004). 
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Chapter Four 
 
  
Results and Discussion 
 
In this chapter, the major experimental results are presented. The first section deals with UV-
absorption spectra. In the second section, the fluorescence spectroscopy results will be shown 
and discussed. The last section will talk about Fourier transform infrared (FTIR) spectroscopy 
results. 
 
4.1 UV-absorption spectroscopy 
 
HSA-drug systems with different concentrations of pentobarbital and propofol were recorded 
and the absorption spectra are shown in (Fig.4.1, and Fig.4.2). The excitation has been done 
on 210 nm and the absorption is recorded at 280 nm. The UV absorbance intensity of HSA 
increased with the increasing of pentobarbital and propofol concentration. In addition, the 
binding of the drugs to HSA resulted in a slight shift of the HSA absorption spectrum. These 
results clearly indicated that an interaction and some complex formation occurred between 
HSA and the two drugs separately. It is evident from the spectra of the pure drugs the little or 
no absorption affect which supports that the resulted peaks are due to the interaction between 
the drugs and HSA. 
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Figure 4.1: UV-absorbance spectra of HSA with different concentrations of pentobarbital 
(a=0.48 mM, b=0.24 mM, c=0.12mM, d=0.06 mM, e=0.03 mM, f=0.015 mM, g=0.0075 mM, 
h=0.00 mM and i = pentobarbital).  
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Figure 4.2: UV-absorbance spectra of HSA with different concentrations of propofol 
(a=1.92 mM, b=1.44 mM, c=0.96 mM, d=0.48 mM, e= 0.24 mM, f=0.00 mM and g= 
propofol). 
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4.1.1 Determination of binding constants (K) by UV absorption spectroscopy 
 
The binding constants can be determined using UV absorption spectroscopy as reported for 
several drug- protein complexes (Stephanos et al, 1996; Klotz et al, 1971; Klotz, 1982; 
stephanos and farina et al, 1996). By assuming that there is only one type of interaction 
between pentobarbital or propofol and HSA in aqueous solution, leads to establish equations. 
(1) and (2) as follows:  
HSA + Pentobarbital ↔ Pentobarbital: HSA                        (1) 
HSA + Propofol ↔ Propofol: HSA 
K = [pentobarbital: HSA]/ [pentobarbital][HSA]                  (2) 
K = [propofol: HSA]/ [propofol][HSA] 
For the weak-binding cases, the absorption data were treated using linear double reciprocal 
plots based on the following equation (Kragh-Hansen, 1981). 
L
1
]0AA[K
1
0AA
1
0AA
1 ⋅−∞
+−∞
=−
         (3) 
Where A0 corresponds to the initial absorption of protein at 280 nm in the absence of ligand, 
A∞ is the final absorption of the ligated-protein, and A is the recorded absorption at different 
pentobarbital or propofol concentrations (L).
 
In order to determine the binding constant (K) by UV-visible spectroscopy we plot 1/ (A-A0) 
vs. 1/ (L). The double reciprocal plot of 1/ (A-A0) vs. 1/ (L) is linear and the binding constant 
(K) can be estimated from the ratio of the intercept to the slope (Fig.4.3, and Fig.4.4). The 
overall binding constant K for pentobarbital-HSA complexes and propofol-HSA complexes 
are estimated to be 1.812×104 M-1, 2.55x103 M-1 respectively. The binding constant value 
obtained are indicative of a relatively weak pentobarbital-HSA and propofol-HSA interaction 
with respect to the other strong drug-HSA complexes with binding constants in the range of 
105 and 106 M-1 (Purcell et al, 2000). The relative weakness of the binding constants may 
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account for the fast effectiveness of these sedative drugs. It is suggested that the relatively 
weaker binding drugs such as propofol, might be more effective at competing with the other 
drugs for binding to HSA. This is due to their availability at sufficiently high concentrations to 
interact, at least potentially, with a large fraction of the HSA molecules (Bhattacharya et al, 
2000). The weak binding of propofol to HSA may contribute to make propofol an ultra–short-
acting sedative-hypnotic agent. The reason for the low stability of the pentobarbital-HSA 
complexes and the propofol-HSA complexes can be attributed to the presence of mainly 
hydrogen bonding interaction between protein donor atoms and the pentobarbital/propofol 
polar groups or an indirect drug-protein interaction through water molecules (Sulkowaska et 
al, 2002).  
 
It has been proposed that anesthetic drugs may exert their effects on proteins at the molecular 
level by attenuating the movement of the local amino acid side chains, which is in turn 
postulated to stabilize certain protein conformations and, hence, affect function (stephanos et 
al, 1996). 
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Figure 4.3:  The plot of 1/ (A-A0) vs. 1/L for HSA with different concentrations of 
pentobarbital. 
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Figure 4.4:  The plot of 1/ (A-A0) vs. 1/L for HSA with different concentrations of propofol. 
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4.2 Fluorescence spectroscopy  
Fluorescence spectroscopy methods are widely used to study binding between ligands and 
proteins. There are three amino acid residues in proteins which are responsible for intrinsic 
fluorescence of the protein: tyrosine (Tyr), phenylalanine (Phe), and tryptophan (Trp). 
Actually, the intrinsic fluorescence of HSA is almost contributed by tryptophan alone, because 
phenylalanine has a very low quantum yield and the fluorescence of tyrosine is almost totally 
quenched if it is ionized or near an amino group, a carboxyl group, or a tryptophan residue 
(Gerbanowski et al, 1999). 
 
Fluorescence intensity of a compound can be decreased by a variety of molecular interactions 
such as molecular rearrangements, excited-state reactions, energy transfer, ground state 
complex formation, and collisional quenching. Such a decrease in intensity is called quenching 
(Fang-Ying et al, 2006). In our experiment for HSA-pentobarbital or propofol we have used 
λex at 360nm and the observed λ emission is 439nm, and 443nm respectively. The 
fluorescence sensor is based on intramolecular charge transfer (ICT), which is highly sensitive 
to the polarity of microenvironment. Therefore, it is expected to act as fluorescent probe for 
some biochemical system like proteins (Tian et al, 2003). 
 
The fluorescence emission spectra of HSA at various concentrations of pentobarbital (0.75, 
1.5, 3.0, 6.0, 12.0, 24.0, and 48.0) ×10-5 mol L-1 are shown in (Fig.4.5). Also the fluorescence 
emission spectra of HSA at various concentrations of propofol (24, 48, 96, 144, and 192) ×10-5 
mol L-1 are shown in (Fig.4.6).  As we can see in (Fig.4.5, and Fig.4.6), the fluorescence 
emission spectra of HSA at various concentrations of pentobarbital or propofol showed that 
HSA had a strong fluorescence emission band at 439 nm, and 443nm respectively. Also it can 
be seen that the fluorescence emission intensity of HSA decreased regularly with the increase 
of concentration of pentobarbital or propofol without changing the shape of the peaks. At the 
same time, a relatively small shift of the maximum emission wavelength occurred. These 
results indicated that the interaction took place between pentobarbital or propofol and HSA. 
And the polarity of microenvironment was changed after the addition of pentobarbital or 
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propofol. The shift in the position of emission peak corresponds to the changes in the polarity 
around the chromophore molecule.  
 
It is concluded that the changes of the HSA secondary structure is related not only due to the 
fluorescence quenching extent but also to the shifts of fluorescence emission wavelength when 
protein interacts with the two drugs. The aromatic ring and the carbonyl groups in the 
pentobarbital molecule, and the aromatic ring and the hydroxyl group in the propofol molecule 
can interact with protein’s hydrophobic and basic amino acid residues respectively. But the 
interaction details and distribution of drug molecules for various HSA–drug complexes may 
be different depending on the structure of the drugs. 
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Figure 4.5: Fluorescence emission spectra of HSA in the absence and presence of 
pentobarbital in these concentrations (a=0.0mM, b=0.0075mM, c=0.015mM, d=0.03mM, 
e=0.06mM, f=0.12mM, g=0.24mM and h=0.48mM). 
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Figure 4.6: Fluorescence emission spectra of HSA in the absence and presence of propofol 
in these concentrations (a=0.0mM, b=0.24mM, c=0.48mM, d=0.96mM, e=1.44mM and 
f=1.92). 
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4.2.1 Determination of Stern-Volmer quenching constants (Ksv) and the quenching rate 
constant of the biomolecule (Kq) 
For fluorescence dynamic quenching, the decrease in intensity is described by the well-known 
Stern–Volmer equation (Chen et al, 1990). 
)L(K1)L(K1
F
F
sv0q
0 +=τ+=     (4) 
Where F and F0 are the fluorescence intensities with and without quencher, Ksv is the Stern-
Volmer quenching constant, and (L) is the concentration of pentobarbital or propofol. The 
Stern–Volmer quenching constants Ksv were obtained by the slope of regression curve 
according the above Equation (4) at different drug concentrations. As we can see from (Fig. 
4.7, Fig.4.8), the Stern-Volmer plots for HSA-pentobarbital or propofol complexes are linear 
and the slopes are equal to Ksv (3.875x107 L mol-1, 9.686x106 L mol-1), respectively. Three 
quenching processes are known as static, dynamic and non-radioactive transfer 
quenching.Fluorescence quenching can be induced by different mechanisms, which were 
usually classified into dynamic quenching and static quenching. Dynamic quenching arises 
from collisional encounters between the fluorophore and quencher, and static quenching 
resulting from the formation of a ground state complex between the fluorophore and the 
quencher (Lakowicz, 2006). 
 
The linear dependence in Stern–Vollmer coordinates indicates homogeneous quenching 
(dynamic or static) in this system. By assuming that dynamic quenching occurs, the Stern–
Volmer quenching constant can be represented as KSV = Kq.τ0, where Kq is the quenching rate 
constant of the biomolecule and τ0 is the average lifetime of the biomolecule without 
quencher. According to the literature, the fluorescence life time τ0 for HSA is about 10-8 s 
(Lakowicz et al, 1973). The obtained values of  quenching rate constants Kq are 3.875x 1015 L 
mol-1s-1, 9.686x1014 L mol-1s-1 are much larger than the maximum dynamic quenching 
constant for various quenchers with biopolymer (2x1010 L.mol-1.s-1) (Wang et al, 2008).  So 
these results confirm that the dynamic quenching is not the main mechanism which causes the 
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fluorescence quenching, and the decrease in fluorescence intensity can be considered as the 
result of static quenching. This implies that the quenching is initiated by the formation of a 
complex (Jiang et al, 2003). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7:  The Stern-Volmer plot for pentobarbital-HSA system. 
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Figure 4.8:  The Stern-Volmer plot for propofol-HSA system. 
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4.2.2 Determination of binding constants (K) by fluorescence spectroscopy  
  
Generally, small molecules interact with macromolecules through four binding modes: 
hydrogen bond, van der Waals force, electrostatic and hydrophobic interactions (Moreno et al, 
1999). The manner in which the fluorescence emission spectra of the bound drug-HSA 
affected by the presence of ligands which bind specifically on the HSA, leads to use the drug 
as a fluorescent probe to determine the environment at the drug binding site and the binding 
constant between drug and  HSA (Tuan et al, 2001; Gao et al, 2000). 
 
For the static quenching, we used the following equation (Lakowicz, 2006) 
( ) 000
111
FLKFFF
+=−       (5) 
where K is the binding constant of drug with HSA. In order to determine the binding constants 
of HSA-pentobarbital and HSA- propofol systems, we plot 1/ (F0-F) versus 1/ [L] of HSA-
drug systems as shown in (Fig.4.9 and Fig.4.10). The plots are linear with (1/F0K) as the slope 
and 1/ F0 as the intercept.  The binding constant K is a quotient of intercept 1/ F0 and slope (1/ 
F0K). The obtained values of K are 1.809x04 M-1, and 2.55x103 M-1 respectively, which agrees 
well with the value obtained earlier by UV spectroscopy and supports the effective role of 
static quenching. The interaction between pentobarbital or propofol with HSA includes the 
hydrophobic interaction between aromatic ring of the two drugs and the hydrophobic amino 
acid residues, and the static interaction between carbonyl groups of pentobarbital, and 
hydroxyl group of propofol with the basic residues. The highly effective quenching constants 
in these cases have lead to a lower value of binding constant between the drug and HSA due to 
effective hydrogen bonding between drugs pentobarbital and propofol and HSA.  
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Figure 4.9:  The plot of 1/ (F0-F) vs. 1/ [L*105] of HSA-pentobarbital system. 
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Figure 4.10:  The plot of 1/ (F0-F) vs. 1/ [L*105] of HSA-propofol system. 
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4.3 Fourier transform infrared (FTIR) spectroscopy 
FTIR spectroscopy has a unique power for detecting H-bonded components of conformer 
mixtures. It can provide quantitative analysis of the secondary structure of proteins without the 
restriction of special amino acids, and its characteristics of high sensitivities, fast analysis and 
low demanding sample preparation make it suitable to analyze the drug–protein interaction at 
all kinds of physiological conditions (Sirotkin et al, 2001; Surewicz et al, 1993; Neault et al, 
2001). Also the most important advantage of FTIR spectroscopy for biological studies is that 
spectra of almost any biological system can be obtained in a wide variety of environments. 
When drugs bind to a globular protein, the intramolecular forces responsible for maintaining 
the secondary and tertiary structures can be altered, resulting in a conformational change of 
the protein (Ganim et al, 2006). So the change of three-dimensional structure of HSA includes 
the transforming of secondary structure in the drug-HSA complex, it can be reflected in the 
infrared absorption spectra. 
 
In order to investigate the changes of the HSA secondary structure after pentobarbital and 
propofol binding to HSA, the FTIR spectroscopy was used. Infrared spectra of proteins exhibit 
a number of so-called amide bands, which represent different vibrations of the peptide 
moieties. The amide group of proteins and polypeptides presents characteristic vibrational 
modes (amide modes) that are sensitive to the protein conformation and have largely been 
constrained to group frequency interpretations (Dukor et al, 2001).  Among the amide bands of 
the protein, amide I band ranging from 1700 to 1600 cm-1 is primarily due to the C=O 
stretching vibration, and has been widely accepted for used (Workman, 1998; Ganim et al, 
2006). Amide II band ranging from 1600 to 1480 cm-1 is primarily due to the coupling of the 
N-H in-plane bending and C-N stretching modes. And amide III band ranging from 1330 to 
1220 cm-1 which is due to  the C-N stretching  mode coupled to the in-plane N - H bending 
mode (Surewicz et al, 1993; Chirgadze et al, 1975; Cai et al,1999), so amide III has more 
characteristics of the protein’s secondary structure than amide II (Deleris et al, 2003), but it 
has not been widely used previously because of its weak intensity and lack of component 
bands ascription. Furthermore, other bands at 1300-900 cm-1 were assigned to C-O bending 
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modes of saccharides (glucose, lactose and glycerol), the peaks at 1430-1360 cm-1 attributed to 
vibrations of certain amino acids chains and 1480-1430 cm-1 is attributed to fatty acids, 
phospholipids and triglycerides (Bramanti et al 1996; Jackson et al, 1991). In this research 
work, our emphasis is on analyzing the protein secondary structure after binding with 
pentobarbital and propofol. 
 
For HSA-pentobarbital interaction and HSA-propofol interaction the second derivative of the 
FT-IR spectrum for free HSA is shown in (Fig.4.11.A, and Fig.4.12.A). From the two figures 
we can see that there are two dominant peaks, one peak at 1656 cm-1 which is related to the 
amide I band, and the other peak at 1544 cm-1 which is related to the amide II band. The spectra 
of HSA-pentobarbital with concentrations (0.0, 0.015, 0.03, 0.06, 0.12, 0.24, and 0.48 mM), 
and the spectra of HSA-propofol with concentrations (0.0, 0.24, 0.48, 0.96, 1.44 and 1.92 mM) 
are shown in (Fig. 4.11.B, and Fig. 4.12.B), respectively. It is evident that, the absorbance 
intensity of HSA decreased regularly with the increase of concentration of pentobarbital and 
propofol. 
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Figure 4.11:    The spectra of (A) HSA-free (second derivative) and (B) HSA-pentobarbital with 
concentrations (a=0.0mM, b=0.015mM, c=0.03mM, d=0.06mM, e=0.12, f=0.24mM, and 
g=0.48mM). 
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Figure 4.12:    The spectra of (A) HSA-free (second derivative) and (B) HSA-propofol with 
concentrations (a=0.0mM, b=0.24mM, c=0.48mM, d=0.96mM, e=1.44mM, and f=1.92mM). 
 
 
 
 
  
76 
 
The peak positions of HSA with different pentobarbital and propofol concentrations for amide 
I, II and III regions are listed in (Table 4.1, and Table 4.2), respectively. For HSA-
pentobarbital interaction, the amide I bands of HSA infrared spectrum shifted as listed in 
table 4.1:  1614 to 1612 cm−1, 1626 to 1627 cm-1,1637 to 1639 cm-1 , 1656 to 1657 cm-1 , 1683 
to 1680 cm-1, and 1693 to 1692 cm-1 after interaction with pentobarbital. In addition a peak at 
1636cm-1 has disappeared after the interaction with pentobarbital. The changes of these peak 
positions and peak shapes demonstrated that the secondary structures of the HSA had been 
changed by the interaction of pentobarbital with HSA. In amide II region some of the peak 
positions have shifted in the following order: 1514 to 1515 cm-1, 1544 to 1548cm-1, 1564 to 
1568 cm-1, 1579 to 1584 cm-1 and 1594 to 1596 cm-1. In addition a peak at 1532 cm-1 remains 
unchanged after the interaction of HSA with pentobarbital. In amide III region little change of 
the peak positions has been observed in the following order: 1242 to 1243 cm-1, 1269 to 1267 
cm-1, 1293 to 1294 cm-1, and 1313 to 1312 cm-1. And the peak at 1226 cm-1 remains 
unchanged after the interaction.  
For HSA-propofol system, the amide I bands of HSA infrared spectrum shifted as listed in 
table 4.2: 1615 to 1611 cm-1, 1624 to 1627 cm-1, 1636 to 1642 cm-1, 1655 to 1659 cm-1, 1682 
to 1678 cm-1, and  1695 to 1691 cm-1 after interaction with propofol. In amide II region the 
peak positions have shifted in the following order: 1515 to 1514 cm-1, 1532 to 1531 cm-1, 1543 
to 1549 cm-1, 1564 to 1567 cm-1, 1577 to 1584 cm-1, and 1594 to 1597 cm-1. In amide III 
region the change of the peak positions is in the following order: 1243 to 1242 cm-1, and 1314 
to 1313 cm-1. There are three peaks at 1226 cm-1, 1268 cm-1, and 1293 do not change after the 
interaction of HSA- propofol. Also, the peak at (1278-1275) appears as new peak in this 
interaction. The changes of these peak positions and peak shapes explained that the secondary 
structures of the HSA had been affected by the interaction of propofol with HSA. 
 
The minor changes in peak positions can be attributed to the effect of the newly imposed H-
bonding between the drug molecules and the protein. It is suggested that, the shift to a higher 
frequency for the major peak in amide I region (1656 to 1657 cm-1) for HSA-pentobarbital 
system, and (1655 to 1659 cm-1) for HSA-propofol system came as a result of stabilization by 
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hydrogen bonding by having the C-N bond assuming partial double bond character due to a 
flow of electrons from the C=O to the C-N bond (Chirgadze et al, 1975).  
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Table 4.1:  Band assignments in the absorbance spectra of HSA with different pentobarbital 
concentrations for amide I, II and III regions. 
 
Bands 
 
HSA  
FREE 
HSA-
Pento. 
0.015 mM 
HSA-
Pento. 
0.03 mM 
HSA-
Pento. 0.06 
mM 
HSA-
Pento. 
0.12mM 
HSA-
Pento. 
0.24mM 
HSA-
Pento. 
0.48mM 
 
 
 
 
 
Amide I 
(1600-1700) 
 
1614 
 
1615 
 
1614 
 
1613 
 
1613 
 
1614 
 
1612 
 
1626 
 
1627 
 
1626 
 
1626 
 
1626 
 
1626 
 
1627 
 
1637 
 
1637 
 
1636 
 
1637 
 
1637 
 
1636 
 
1639 
 
1656 
 
1657 
 
1656 
 
1656 
 
1656 
 
1654 
 
1657 
 
1683 
 
1680 
 
1681 
 
1682 
 
1681 
 
1682 
 
1680 
 
1693 
 
1691 
 
1692 
 
1693 
 
1692 
 
1694 
 
1692 
 
 
 
Amide II 
(1480-1600) 
 
 
1514 
 
1515 
 
1515 
 
1515 
 
1515 
 
1515 
 
1515 
 
1532 
 
1532 
 
1532 
 
1531 
 
1531 
 
1531 
 
1532 
 
1544 
 
1548 
 
1546 
 
1546 
 
1546 
 
1544 
 
1548 
 
1564 
 
1568 
 
1570 
 
1571 
 
1570 
 
1571 
 
1568 
 
1579 
 
1579 
 
1582 
 
1581 
 
1581 
 
1585 
 
1584 
 
1594 
 
1595 
 
1595 
 
1595 
 
1595 
 
1594 
 
1596 
 
 
 
 
Amide III 
(1220-1330) 
 
1226 
 
1226 
 
1226 
 
1226 
 
1226 
 
1226 
 
1226 
 
1242 
 
1243 
 
1243 
 
1243 
 
1243 
 
1242 
 
1243 
 
1269 
 
1267 
 
1269 
 
1268 
 
1268 
 
1268 
 
1267 
 
1293 
 
1292 
 
1293 
 
1294 
 
1293 
 
1293 
 
1294 
 
1313 
 
1312 
 
1313 
 
1314 
 
1313 
 
1313 
 
1312 
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Table 4.2: Band assignments in the absorbance spectra of HSA with different propofol 
concentrations for amide I, II and III regions. 
Bands HSA FREE HSA-Prop 
0.24 mM 
HSA-Prop 
0.48 mM 
HSA-Prop 
0.96 mM 
HSA-Prop 
1.44mM 
HSA-Prop 
1.92mM 
 
 
 
Amide I 
(1600-1700) 
 
1615 
 
1612 
 
1611 
 
1616 
 
1617 
 
1611 
 
1624 
 
1627 
 
1628 
 
1626 
 
1625 
 
1627 
 
1636 
 
1640 
 
1642 
 
1638 
 
1637 
 
1642 
 
1655 
 
1657 
 
1658 
 
1657 
 
1656 
 
1659 
 
1682 
 
1680 
 
1677 
 
1681 
 
1682 
 
1678 
 
1695 
 
1692 
 
1691 
 
1693 
 
1693 
 
1691 
 
 
 
Amide II 
(1480-1600) 
 
1515 
 
1515 
 
1514 
 
1516 
 
1516 
 
1514 
 
1532 
 
1532 
 
1531 
 
1532 
 
1532 
 
1531 
 
1543 
 
1549 
 
1549 
 
1548 
 
1546 
 
1549 
 
1564 
 
1568 
 
1566 
 
1570 
 
1571 
 
1567 
 
1577 
 
1583 
 
1583 
 
1590 
 
1578 
 
1584 
 
1594 
 
1597 
 
1598 
 
1594 
 
1592 
 
1597 
 
 
 
 
Amide III 
(1220-1330) 
 
1226 
 
1226 
 
1226 
 
1226 
 
1226 
 
1226 
 
1243 
 
1242 
 
1243 
 
1243 
 
1243 
 
1242 
 
1268 
 
1267 
 
1269 
 
1268 
 
1268 
 
1268 
  
1278 
 
1278 
 
1275 
 
1275 
 
1275 
 
1293 
 
1294 
 
1293 
 
1294 
 
1293 
 
1293 
 
1314 
 
1311 
 
1313 
 
1314 
 
1313 
 
1313 
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The difference spectra [(protein + pentobarbital or propofol) – (protein)] were obtained in 
order to monitor the intensity variations and the results are shown in (Fig.4.13, Fig.4.14, 
Fig.4.15, and Fig.4.16). For HSA-pentobarbital interaction, Fig. (4.13) shows FTIR spectra 
(top two curves) and difference spectra of HSA and its complexes with different pentobarbital 
concentrations in the amide I and amide II regions. 
 
 In  the amide I region, there are one strong negative feature at 1654 cm-1 plus one weak 
negative feature  at 1616 cm-1 . For the amide II region, there is a strong negative feature at 
1543 cm-1 plus a weak negative feature at 1575 cm-1. Fig.(4.14) shows that in amide III region 
there are two strong negative features at 1317 cm-1, and 1242 cm-1. These features were 
observed at low pentobarbital concentration (0.03mM). For HSA-propofol interaction, 
Fig.(4.15) shows FTIR spectra (top two curves) and difference spectra of HSA and its 
complexes with different propofol concentrations in the amide I and amide II regions. At low 
propofol concentration (0.48 mM), one strong negative feature at 1652 cm-1 is observed in 
amide I region, while in amide II region there is a strong negative feature at 1548 cm-1 in 
addition to one weak negative feature at 1513 cm-1. For low propofol concentration (0.48 mM) 
Fig.(4.16) shows that in amide III region there are two strong negative features at 1242 cm-1, 
and 1315 cm-1. It is clearly shown that the strong negative features became stronger as 
pentobarbital or propofol concentration was increased to 0.03, 0.06, and 0.48 mM, and 0.48, 
0.96, 1.44, and 1.92 mM respectively with a little shift in their positions.  
 
The observed negative features are attributed to the decrease in the intensity of the  amide I 
band at1655 cm-1, amide II band at 1543 cm-1, and amide III band at 1242 cm-1, and 1313 cm-1 
as a result of drug interaction (H-bonding) with protein C=O and C-N groups (Purcell et al, 
2000). The decrease in the intensity in amide I, II, and III regions is due to the reduction of the 
α-helix structure in HSA, upon pentobarbital or propofol interactions, which will determine 
and will be discussed later.  The band at 1515 cm-1 of the HSA free is due to the tyrosine 
amino acid side chain vibration (Matsuura et al, 1986; Olinger et al, 1986; Fabian et al, 1994; 
Yamamoto et al, 1991; Byler et al, 1986) showed  no spectral changes upon pentobarbital or 
propofol complexation (Fig.4.13, Fig.4.15).  
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Figure 4.13:  FTIR spectra (top two curves) and difference spectra of HSA and its complexes 
with different pentobarbital concentrations in the region of 1800- 1500 cm-1. 
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Figure 4.14: FTIR spectra (top two curves) and difference spectra of HSA and its complexes with 
different pentobarbital concentrations in the region of 1330- 1220 cm-1. 
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Figure 4.15:  FTIR spectra (top two curves) and difference spectra of HSA and its complexes 
with different propofol concentrations in the region of 1800- 1500 cm-1. 
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Figure 4.16: FTIR spectra (top two curves) and difference spectra of HSA and its complexes with 
different propofol concentrations in the region of 1330- 1220 cm-1. 
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The Determination of the secondary structure of HSA and its pentobarbital or propofol 
complexes were carried out on the basis of the procedure described by Byler and Susi (Byler 
et al, 1986). In our work a quantitative analysis of the protein secondary structure for the free 
HSA, pentobarbital–HSA, and propofol-HSA complexes in dehydrated films are determined 
from the shape of amide I, II and III bands. Baseline correction was carried out in the range of 
(1700–1600), (1600-1480), and (1330–1220 cm-1) to get amide I, II, and III bands. Then 
Fourier self-deconvolution and second derivative were applied to these three ranges 
respectively to increase spectral resolution and therefore to estimate the number, position and 
the area of each component bands. Based on these parameters, a curve-fitting process was 
carried out by Opus software (version 5.5) to obtain the best Lorentzian-shaped curves that fit 
the original HSA spectrum. The individual bands are identified with its representative 
secondary structure, and the content of each secondary structure of HSA is calculated by area 
of their respective component bands. The procedure was in general carried out considering 
only components detected by second derivatives and the half widths at half height (HWHH) 
for the component peaks are kept around 5cm-1. 
The component bands of amide I were attributed according to the well-established assignment 
criterion (Jiang et al, 2004; Ivanov et al, 1994). The amide I bands range 1610–1640 cm-1 are 
generally assigned to β-sheet, 1640–1650 cm-1 to random coil, 1650–1658 cm-1 to α-helix,  and 
1660–1700 cm-1 to β-turn structure. For amide II, the absorption band consists of four 
components and assigned in the following order: 1488-1500 cm-1 to β-sheets, 1504-1525 cm-1 
to random coil, 1527-1560 cm-1 to α-helix and 1564-1585cm-1 to turn structure (Rahmelow et 
al, 1996). The component bands of amide III have been assigned as follows: α-helix 1330–
1290 cm-1, β-turn 1290–1270 cm-1, random coil 1270–1250 cm-1 and β-sheet 1250–1220 cm-1 
(Ivanov et al, 1994). Most investigations have concentrated on amide I band assuming higher 
sensitivity to the change of protein secondary structure (Erik et al, 2006). However, it has been 
reported that the amide II band has high information content and could be used alone for 
prediction of secondary structure in place of amide I (Oberg et al, 2004; Fu et al, 1994). Others 
have reported that amide III is not directly affected by the strong water band and therefore it 
has been used for structure determination (Goormaghtigh et al, 1999).  
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Based on the above assignments, the percentages of each secondary structure of HSA were 
calculated from the integrated areas of the component bands in amide I, II, and III respectively. 
Where the area of all the component bands assigned to a given conformation is then summed 
and divided by the total area. The obtained number is taken as the proportion of the polypeptide 
chain in that conformation.  
The Secondary structure determination for the free HSA and its pentobarbital or propofol 
complexes with different drug concentrations are given in (Table 4.3, and Table 4.4). The 
second  derivative resolution enhancement and curve – fitted amide I, amide II, and amide III 
regions and secondary structure determinations of the free human serum albumin (A, B) and its 
pentobarbital or propofol complexes (C, D) with the highest concentrations in dehydrated films 
are shown in (Fig. 4.17, Fig.4.18, Fig. 4.19, Fig. 4.20, Fig. 4.21, and Fig.4.22).  It is generally 
accepted that infrared spectra of proteins in films and in solution may display distinct 
differences, but these differences are due to the presence or absence of the water or buffer 
molecules that imprint their mark on the spectra. It has been shown that the structural 
information content is of the same quality in films and in solution with an (error of < 1%) for 
both systems with respect to amide regions (Ahmed Ouameur et al, 2004). 
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Table 4.3:   Secondary structure determination for amide I, II and III regions in HSA and its 
pentobarbital complexes.  
 
Bands 
HSA  
FREE 
HSA-Pento. 
0.015 mM 
HSA-Pento. 
0.03 mM 
HSA-Pento. 
0.06 mM 
HSA-Pento. 
0.12mM 
HSA-Pento. 
0.24mM 
HSA-Pento. 
0.48mM 
Amide I 
β-sheets(cm-1) 
(1610-1640) 
(1680-1700) 
 
16 
 
18 
 
16 
 
18 
 
17 
 
17 
 
19 
 
Random(cm-1) 
(1640-1650) 
 
 
15 
 
 
14 
 
 
16 
 
 
16 
 
 
16 
 
 
18 
 
 
13 
 
α –helix(cm-1) 
(1650-1660) 
 
 
55 
 
 
51 
 
 
51 
 
 
49 
 
 
49 
 
 
49 
 
 
48 
 
Turn (cm-1) 
(1660-1680) 
 
 
 
14 
 
 
17 
 
 
17 
 
 
17 
 
 
16 
 
 
16 
 
 
20 
Amide II 
β-sheets(cm-1) 
(1488-1500) 
(1587-1598) 
 
18 
 
18 
 
17 
 
17 
 
18 
 
17 
 
19 
 
Random(cm-1) 
(1504-1525) 
 
 
14 
 
 
11 
 
 
12 
 
 
14 
 
 
13 
 
 
14 
 
 
10 
 
α –helix(cm-1) 
(1527-1560) 
 
 
50 
 
 
50 
 
 
51 
 
 
48 
 
 
50 
 
 
50 
 
 
47 
 
Turn (cm-1) 
(1564-1585) 
 
 
18 
 
 
21 
 
 
20 
 
 
21 
 
 
19 
 
 
19 
 
 
24 
Amide III 
 
β-sheets(cm-1) 
(1220-1250) 
 
 
17 
 
 
17 
 
 
18 
 
 
19 
 
 
20 
 
 
20 
 
 
21 
 
Random(cm-1) 
(1250-1270) 
 
 
15 
 
 
16 
 
 
15 
 
 
16 
 
 
15 
 
 
16 
 
 
16 
 
Turn (cm-1) 
(1270-1290) 
 
 
18 
 
 
18 
 
 
18 
 
 
17 
 
 
17 
 
 
17 
 
 
17 
 
α –helix(cm-1) 
(1290-1330) 
 
 
50 
 
 
49 
 
 
49 
 
 
48 
 
 
48 
 
 
47 
 
 
46 
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Table 4.4:  Secondary structure determination for amide I, II and III regions in HSA and its 
propofol complexes. 
 
Bands 
HSA 
FREE 
HSA-Prop. 
0.24 mM 
HSA-Prop. 
0.48 mM 
HSA-Prop. 
0.96 mM 
HSA-Prop. 
1.44mM 
HSA-Prop. 
1.92mM 
Amide I 
β-sheets(cm-1) 
(1603-1635) 
(1687-1700) 
 
16 
 
32 
 
32 
 
 
 
32 
 
 
 
36 
 
 
 
39 
 
 
Random(cm-1) 
(1635-1645) 
 
15 
 
6 
 
6 
 
5 
 
5 
 
5 
 
α –helix(cm-1) 
(1648-1670) 
 
55 
 
52 
 
52 
 
50 
 
49 
 
46 
 
Turn (cm-1) 
(1670-1685) 
 
14 
 
10 
 
10 
 
13 
 
10 
 
10 
Amide II 
β-sheets(cm-1) 
(1488-1504) 
(1585-1600) 
 
18 
 
23 
 
 
 
25 
 
 
 
27 
 
 
 
29 
 
 
 
29 
 
 
Random(cm-1) 
(1504-1525) 
 
14 
 
15 
 
14 
 
14 
 
15 
 
15 
 
α –helix(cm-1) 
(1527-1560) 
 
50 
 
47 
 
46 
 
45 
 
43 
 
42 
 
Turn (cm-1) 
(1564-1585) 
 
18 
 
15 
 
15 
 
14 
 
13 
 
14 
Amide III 
β-sheets(cm-1) 
(1220-1250) 
 
17 
 
22 
 
22 
 
21 
 
20 
 
21 
 
Random(cm-1) 
(1250-1270) 
 
15 
 
15 
 
16 
 
16 
 
17 
 
17 
 
Turn (cm-1) 
(1270-1290) 
 
18 
 
18 
 
18 
 
20 
 
21 
 
21 
 
α –helix(cm-1) 
(1290-1330) 
 
50 
 
45 
 
44 
 
43 
 
42 
 
41 
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Figure 4.17:  Second-derivative resolution enhancement and curve-fitted amide I region 
(1700-1612 cm-1) and secondary structure determination of the free human serum albumin 
(A,B) and its pentobarbital complexes (C,D) with 0.48mM drug concentration.   
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Figure 4.18:  Second-derivative resolution enhancement and curve-fitted amide II region 
(1600-1480 cm-1) and secondary structure determination of the free human serum albumin 
(A,B) and its pentobarbital complexes (C,D) with 0.48mM drug concentration.   
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Figure 4.19:  Second-derivative resolution enhancement and curve-fitted amide III  region 
(1330-1220 cm-1) and secondary structure determination of the free human serum albumin 
(A,B) and its pentobarbital complexes (C,D) with 0.48mM drug concentration.   
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Figure 4.20:  Second-derivative resolution enhancement and curve-fitted amide I region 
(1700-1612 cm-1) and secondary structure determination of the free human serum albumin 
(A,B) and its propofol complexes (C,D) with 1.92mM drug concentration.   
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Figure 4.21:  Second-derivative resolution enhancement and curve-fitted amide II region 
(1600-1480 cm-1) and secondary structure determination of the free human serum albumin 
(A,B) and its propofol complexes (C,D) with 1.92mM drug concentration.   
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Figure 4.22:  Second-derivative resolution enhancement and curve-fitted amide III  region 
(1330-1220 cm-1) and secondary structure determination of the free human serum albumin 
(A,B) and its propofol complexes (C,D) with 0.48mM drug concentration. 
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The percentage values for the components of amid I of free HSA are consistent with the 
results of other recent spectroscopic studies (Beauchemin et al, 2007; Bai et al, 1994). The 
results of amide II and amide III showed similar trends in their percentage values to that of 
amide I.  In amide I region, the free HSA contained major amounts of α-helical (55%), β- 
sheet (16%), random coil (15 %), and β-turn structure (14%). We can see from Fig 4.17 and 
Table 4.3, as a result of HSA-pentobarbital interaction that the α-helical structure reduced 
from 55% to 48%, β-sheet increased from 16% to 19% , β-turn structure increased from 14% 
to 20%, and the random coil reduced from 15% to 13%. For HSA-propofol system, Fig. (4.20) 
and Table (4.4) show that the α-helical structure reduced from 55% to 46%, β-sheet increased 
from 16% to 39%, β-turn structure decreased from 14% to 10%, and the random coil reduced 
from 15% to 5% after interaction of propofol with HSA.   
 
In amide II region, the free HSA contained α-helical (50%), β-sheet (18%), random coil (14 
%), and β-turn structure (18%). With regard to the pentobarbital–HSA complex, the α-helical 
structure reduced from 50% to 47%, β-sheet increased from 18% to 19%, β-turn structure 
increased from 18% to 24%, and the random coil reduced from 14% to 10% (Fig.4.18 and 
Table 4.3). For HSA-propofol system, Fig. (4.21) and Table (4.4) show that the α-helical 
structure reduced from 50% to 42%, β-sheet increased from 18% to 29%, β-turn structure 
reduced from 18% to 14%, and the random coil increased from 14% to 15% after interaction 
of propofol with HSA. 
 In amide III region, HSA free contained α-helical (50%), β-sheet (17%), random coil (15%), 
and β-turn structure (18%). Upon pentobarbital complexation, the α-helical structure reduced 
from 50% to 46%, β-sheet increased from 17% to 21%, β-turn structure decreased from 18% 
to 17%, and the random coil increased from 15% to 16% (Fig4.19, and Table 4.3). For HSA-
propofol system, the α-helical structure reduced from 50% to 41%, β-sheet increased from 
17% to 21%, β-turn structure increased from 18% to 21%, and the random coil increased from 
15% to 17% (Fig.4.22 and Table 4.4). 
The decrease of α-helix percentage with the increase of pentobarbital and propofol 
concentrations is evident in the calculations and this trend is consistent in the three amide 
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regions. However for the β-sheet the relative percentage has increased with increasing 
pentobarbital and propofol concentrations. The reduction of α-helix intensity percentage in 
favour of the increase of β-sheets and turn structure are believed to be due to the unfolding of 
the protein in the presence of pentobarbital and propofol as a result of the formation of H-
bonding between HSA and the drug. Similar conformational transitions from an α-helix to β-
sheet structure were observed for the protein unfolding upon protonation and heat denaturation 
(Beauchemin et al, 2007). These results indicate that pentobarbital and propofol interact with 
HSA through C=O and C-N groups in the HSA polypeptides. The pentobarbital and propofol–
HSA complexes caused the rearrangement of the polypeptide carbonyl hydrogen bonding 
network and finally the reduction of the protein α-helical structure. 
 
The steric blocking effect can contribute an enthalpic stabilization to intra-protein hydrogen 
bonds and disfavors peptide to catalyst complexation in hydrogen exchange reactions and 
peptide to peptide H-bonding in the helical main chain conformation but not in β-strands (Kim 
et al, 1993).  The newly formed H-bonding result in the C-N bond assuming partial double 
bond character due to a flow of electrons from the C=O to the C-N bond which decreases the 
intensity of the original vibrations (Chirgadze et al, 1975). It seems that the H-bonding affects 
more of the original bonding in α- helix than in β-sheets depending on the accessibility of the 
solvent and on propensities of α- helix and β-sheets of the HSA (Parker, 1983). The hydrogen 
bonds in α- helix are formed inside the helix and parallel to the helix axis, while for β-sheet 
the hydrogen bonds take position in the planes of β-sheets as the preferred orientations 
especially in the anti-parallel sheets. The restrictions on the formation of hydrogen bonds in β-
sheet relative to the case in α- helix explains the larger effect on reducing the intensity 
percentage of α- helix to that of β-sheet (Holzbaur et al, 1996; Zhang et al, 1999).  
 
Pentobarbital and propofol complexes mainly induce changes in protein conformation of HSA 
from α-helix to β- turn, which indicates a partial unfolding of the HSA molecular upon 
pentobarbital and propofol interaction. The HSA–pentobarbital interaction was the strongest 
among the two drugs, since the pentobarbital binding to HSA is greater than propofol binding 
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to HSA. Depending on the chemical structures of the two drugs; there are more side 
interactions in presence of pentobarbital (Heterocyclic aromatic side and three different 
locations of carbonyl group) to interact with HSA, while in the presence of propofol there is 
one side group (hydroxyl group) that has the ability to interact with the HSA protein. 
Therefore, the binding constant of pentobarbital with HSA is greater than the binding constant 
of propofol with HSA molecule. Hence from my study, I can say that the pentobarbital binds 
with HSA more strongly than propofol, so it has the more deposition time in human plasma to 
release its function (Zhang et al, 1999). And propofol has a faster sedation than pentobarbital. 
The obtained results of pentobarbital and propofol in our study are similar to those previously 
reported (Pershad et al, 2007) they showed that propofol offered significantly shorter sedation 
induction time, recovery time, total sedation time, time to return to baseline functional status, 
and permits faster onset recovery than pentobarbital with comparable efficacy for sedation 
(Bassett et al, 2003). 
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Chapter Five 
 
Conclusions and Future work 
5.1 Conclusions 
 
Pentobarbital and propofol are anesthetic drugs and their interaction with serum albumin is of 
prime significance. I have studied the interaction of anesthetic drugs pentobarbital and 
propofol with HSA using UV-absorption spectroscopy, fluorescence spectroscopy and by 
FTIR spectroscopy. I have determined the binding parameters for the binding of pentobarbital 
or propofol with HSA: For HSA-pentobarbital and HSA-propofol complexes, the binding 
constants by using UV-absorption spectroscopy are estimated to be K= 1.812×104 M-1, 
2.55x103 M-1 respectively, also the obtained values of K by using fluorescence spectroscopy 
are 1.809x04 M-1, and 2.55x103 M-1 respectively, which agree well with the value obtained 
earlier by UV spectroscopy. In addition, the values of  Stern–Volmer quenching constants and 
quenching rate constants for both pentobarbital and propofol are estimated to be (3.875x107 L 
mol-1, 3.875x 1015 L mol-1s-1), and (9.686x106 L mol-1, 9.686x1014 L mol-1s-1) respectively.   
 
These experimental results confirm that the dynamic process is not the main mechanism which 
causes the fluorescence quenching, and the decrease in fluorescence intensity can be 
considered as a result of static quenching, which is indicative of a complex formation between 
the protein and the drug molecule. Also the lower value of binding constant between the drug 
and HSA is due to the effective hydrogen bonding between drugs (pentobarbital and propofol) 
and HSA.  
 
Analysis of the FTIR spectra reveals that HSA–pentobarbital and HSA-propofol interactions 
induce intensity reduction in the absorption bands of α-helix and β-sheets components with 
different proportionality due to the different accessibility of H-bond formation in these 
components. This means that the drug–HSA combination caused the rearrangement of the 
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protein polypeptide chain and changes of the protein’s secondary structure. We inferred that 
the binding forces that involve in the binding process besides hydrophobic interaction are 
electrostatic attraction and hydrogen bonding.  
 
The conclusion can be drawn that the (carbonyl groups and N-H  groups) and the hydroxyl 
group which are substituted on aromatic ring of pentobarbital and propofol respectively play 
an important role for reduction of percentage content of α-helix structure in drug–HSA 
interaction. When pentobarbital and propofol interact with hydrophobic pockets of HSA, their 
carbonyl groups and hydroxyl group can interact with the C=O and C–N groups in the protein 
polypeptides chain forming hydrogen bonding. The interactions caused the rearrangement of 
the polypeptide carbonyl hydrogen bonding network, then the reduction of HSA α-helix 
structure. 
 
Drug interactions will in most cases significantly affect the apparent distribution volume of the 
drugs and also affect the elimination rate and determine the therapeutic affectivity of drugs. 
These experimental data may be a useful guide for pentobarbital and propofol efficient drug 
design, and provide some important data for clinical study of these two drugs. 
 
5.2 Future work 
 
The binding study of pentobarbital or propofol with HSA is of great importance in 
pharmacology and biochemistry. Our research can supply some important information to 
clinical research and provide the theoretical basis for the new drug design. Therefore, this 
research needs further studies to be a useful guide for synthesis of efficient pentobarbital and 
propofol drugs such as the determinations of binding sites, binding location, and 
thermodynamic parameters (enthalpy, free energy, entropy) at different temperatures to 
deduce the type of the acting force for the binding reaction between pentobarbital or propofol 
and HSA.  
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Furthermore, effects of ions on the binding constants need to be investigated, because the 
existence of metal ions can directly influence the binding force of drug with protein, thus 
affecting the storage time of the drug in blood plasma and enhancing the maximum 
effectiveness of the drug. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
102 
 
References 
Ahmed Quamour, A., et al. (2004). Biopolymers, 73, p503. 
 
Bryson, H. M., Fulton, B. R., Faulds, D. (1995). Drugs, 50, p513. 
 
Bhattacharya, A., Gruene, T., Curry, S. (2000). Journal of Molecular Biology. 303, p721. 
 
Bertucci, C., Ascoli, G., Barretta, G. U., Bari, L. D., Salvadori, P. (1995). Journal of 
Pharmaceutical and Biomedical Analysis, 13, p1087. 
 
Bellamy, L. J. (1954). The Infrared Spectra of Complex Molecules. Methuen, London. 
 
Britlain, E. F. H., George, W. O., Wells, C. H. J. (1970): Introduction to Molecular 
Spectroscopy, Academic Press, London. 
 
Barrow. G. M. (1962): Introduction to Molecular Spectroscopy, McGraw-Hill, New York. 
 
Blitz, J. P. and  Augustine, S. M. (1994). Spectroscopy, 9, p28. 
 
Bellamy, L. J. (1975): The Infrared Spectra of Complex Molecules, 3rd ed., John Wiley, New 
York. 
 
Berlman, I.B. (1971). Handbook of fluorescence spectra of aromatic molecules, 2nd ed. 
Academic Press, New York. 
 
Byler, D.M. and Susi, H. (1986). Biopolymers 25, p469. 
 
Bell, R. J. (1972): Introduction Fourier Transform Spectroscopy. Academic Press, New York.  
 
Bhattacharya, A. A. Curry, S., Franks, N. P. (2000). Journal of Biological Chemistry, 275, 49, 
p38738. 
 
Bramanti, E. and Benedetti, E. (1996). Biopolymers 38, p639. 
 
Byler, D. M., Brouilette, J. N., Susi, H. (1986). Spectroscopy 1, p39. 
 
Beauchemin, R., et al. (2007). Biomacromolecules 8, p3177. 
 
Bai, Y. and Englander, S. W. (1994). Proteins 18, p262. 
 
Bassett, K. E, Anderson, J. L., Pribble, C. G, Guenther, E. (2003). Journal Annals of 
Emergency Medicine, 42, p773. 
 
  
103 
 
Curry, S., Mandelkow, H., Brick, P., Franks, N. (1998). Natural Structural Biology, 5, p827. 
 
Curry, S., Brick P., Franks, N. P. (1999). Biochimica et Biophysica Acta, 1441, p131. 
 
Cui, F. L., Fan, J., Li, J. P., Hu, Z. D. (2004). Bioorganic and Medicinal Chemistry, 12, p151. 
 
Cui, F. L., et al. (2006). Biopolymers  83, p170. 
 
Cui, F. L., Wang, J. L., Cui, Y. R., Li, J. P. (2006). Analytica Chimica Acta, 571, p175. 
 
Coblentz, W. W. (1951): From the Life of a Researcher, Philosophical Library, New York. 
 
Chang, R. (1971): Basic Principles of Spectroscopy, McGraw-Hill, New York. 
 
Colthrup, N.,  Daly, L.  Wiberley, S. (1990): Introduction to Infrared and Raman pectroscopy. 
3rd ed. Academic Press, New York. 
 
Clark, B. G., Frost, T.,  Russell, M. A. (1993): UV Spectroscopy: techniques, nstrumentation, 
data handing. 1st ed., Chapman Hall, London. 
 
Chen, G. Z., Huang, X. Z., Xu, J. G., Zheng, Z. Z., Wang, Z. B. (1990): Method of 
Fluorescence Analysis, Science Press, Beijing. 
 
Chirgadze, Y. N., Fedorov, O. V., Trushina, N. P. (1975). Biopolymers 14, p679. 
 
Cai, S. W. and Snghl, B. R. (1999). Biophysical Chemistry 80, p7. 
 
Deepa, S. and Mishra, A. K. (2005). Journal of Pharmaceutical and Biomedical Analysis, 38, 
p556. 
 
Duxbury, G. (1999):  Infrared Vibration–Rotation Spectroscopy, John Wiley, Chichester. 
 
Donald P. (2001): Introduction to spectroscopy. 4th ed. Cengage learning. USA. 
 
Dukor, R. K., Chalmers, J. M., Griffiths, P. R. (Eds). (2001): Vibrational Spectroscopy in the  
Detection of Cancer, in Handbook of Vibrational Spectroscopy, vol. 5, John Wiley and Sons, 
Chichester. 
 
Donald, C. (2003): Essentials of pharmaceutical chemistry, 3rd ed., Pharmaceutical Press, 
London. 
 
Deleris, G. and Petibios, C. (2003). Vibrational Spectroscopy, 32, p129. 
 
  
104 
 
Edward M, G., Maged, S. M., Michael, J. M (1995): Clinical anaesthesiology, 4th ed.Mc Graw 
Hill, US. 
 
Elliott, A. and Ambrose. E. (1950). Nature 165, p921. 
 
Erik, G., Jean-Marie, R., Vincent, R. (2006). Biophysical Journal, 90, p2946. 
 
Fu, F. N., DeOliveira, D. B., Trumble, W. R., Sarkar, H. K., Singh, P. R. (1994). Applied 
Spectroscopy, 48, p1432. 
 
Fabian, H. et al. (1994). Biochemistry 33, p10725. 
 
Fang-Ying, W., Zhao-Jun, J, Yu-Mei, W., Xiao-Fen, W. (2006). Chemical Physics Letters 
424, p387. 
 
Ferraro, J, R. And Basilo, L. J. (1979): Fourier Transform Infrared Spectroscopy. Applications 
to Chemical Systems, Academic Press, New York. 
 
Filyasova, A. I., Kudelina, I. A., Feofanov, A. V. (2001).  Journal of Molecular Structure, 173, 
p565. 
 
Fulton, B. and Sorkin, E.M. (1995). Drugs. 50, p636. 
 
Goormaghtigh, E., Raussens, V., Ruysschaert, J. M. (1999). Biochimica et Biophysica Acta  
1422, p105. 
 
Ganim, Z. and Tokmakoff, A. (2006). Biophysical Journal, 91, p2636. 
 
Gao, T., Ci, Y. X., Jian, H. Y., An, C. (2000). Vibrational Spectroscopy 24, p225. 
 
Gerbanowski, A. Malabat, C. Rabiller, C. Gueguen, J. (1999). Journal of Agricultural and 
Food Chemistry, 47, p5218. 
 
Griffiths, P. R. and Hareth, J. D. (1986): Fourier Transform Infrared Spectroscopy, Wiley, 
New York. 
 
Gans, P. (1971): Vibrational Molecules: an Introduction to the Interpretation of Infrared and 
Raman Spectra, Chapman and Hall, London. 
 
Gordon, G. H. (2005): Spectroscopy for the biological Sciences. John Wiley & Sons. Canada. 
 
Holzbaur, I. E., English, A. M., Ismail, A. A. (1996). Biochemistry 35, p5488. 
 
  
105 
 
Houck, M. S. (2006): Fundamentals of forensic science, Elsevier Academic Press, Burlington, 
MA. 
 
Herzberg, G. (1989): Molecular Spectra and Molecular Structure I. Spectra of Diatomic 
Molecules, 2nd ed., Krieger, Florida. 
 
Herzberg, G. (1991): Molecular Spectra and Molecular Structure.II. Infrared and Raman 
Spectra of Polyatomic Molecules, Krieger, Florida. 
 
Herschel, F. W. (1800). Philos. Trans. R. Soc. London. 
 
Howarth, O. (1973): Theory of Spectroscopy, Thomas Nelson and Sons, London. 
 
Herzberg, G. (1945): Infrared and Raman Spectra of Polyatomic Molecules, Van Nostrand 
Reinhold, New York. 
 
He, W. Y., Li, Y., Tian, J. N., Liu, H. X., Hu, Z. D., Chen, X. G. (2005).  Journal of 
Photochemistry and Photobiology A: Chemistry, 174, p53. 
 
Herve, F., Urien, S., Albengres, E., Duche, J.C., Tillement, J. (1994). Clinical 
Pharmacokinetics, 26, p44. 
 
Hannallah, R.S. et al. (1991). Anesthesiology,74, p217. 
 
Hetzer, B. E., and Krekow, L. K. (1999). Neurotoxicol Teratol, 21, p181. 
 
Hodes, J. E., Soncrant, T. T., Larson, D. M., Carlson, S. G., Rapoport,S. I. (1985).  
Anesthesiology  63, p633. 
 
Il'ichev, Y. V., Perry, J. L., Simon, J. D. (2002). Journal of Physical Chemistry B, 106, p460. 
 
Ivanov, A. I. et al. (1994). Journal of Applied Spectroscopy, 60, p305. 
 
Jiang, C. Q., Gao, M. X., Meng, X. Z.(2003). Spectrochimica Acta Part A: Molecular and 
Biomolecular Spectroscopy, 59, p1605. 
 
Jones, R. N. and Sandorfy, C. (1956): The application of Infrared and Raman Spectrometry to 
the Elucidation of Molecular Structure. In: W. West, (Ed.) Chemical Applications of 
Spectroscopy. Interscience, New York. 
 
Jackson, M. and Mantsch, H. H. (1991). Journal of Biological Chemistry, 69, p639. 
 
Jiang, M., Xie, M. X.,  Zheng, D., Liu, Y., Li, X. Y., Chen, X. (2004). Journal of Molecular 
Structure, p692. 
  
106 
 
Kragh-Hansen, U. (1981). Pharmacological Reviews, 33, p17. 
 
Kragh-Hansen, U., Chuang, V.T.G., Otagiri, M. (2002). Biological and Pharmaceutical 
Bulletin, 25, 695. 
 
Krishnakumar, S. S. and Panda, D. (2002). Biochemistry 41, p7443. 
 
Kragh-Hansen, U. (1990). Danish Medical Bulletin, 37, p57. 
 
Kandagal, P. B. et al. (2006). Journal of Pharmaceutical and Biomedical Analysis, 41, p393. 
 
Krimm, S., Bandekar, J. (1986). Advances in Protein Chemistry, 38, p181. 
 
Kalsi. P. S. (2004): Spectroscopy of Organic Compounds. 6th ed. New Age International (P) 
Ltd.,  New Delhi. 
 
Kim, C. A. and  Berg, J. M. (1993). Nature 362, p267. 
 
Klotz, M. I. And Hunston, L. D. (1971). Biochemistry 10, 3065. 
 
Kendrew, J. C. et al. (1958). Nature 18, 662-666. 
 
Kauppinnen, J. K., Moffatt, D. J., Mantsch, H. H., Cameron, D. G. (1981). Applied 
Spectroscopy, 18, p35. 
 
Klotz, M. I. (1982). Science 217, p1247. 
 
Leslie, S. and Richard, D. (1993): The Focal encyclopaedia of photography. 3rd ed, Elsevier 
group. 
 
Lakowicz, J. R. (2006): Principles of Fluorescence Spectroscopy, 3rd ed., Springer science. 
Maryland, USA. 
 
Lakowicz, J. R. (1991): Topics in Fluorescence Spectroscopy: Principles, Plenum Press. New 
York. 
 
Lakowicz, J. R. and  Weber, G. (1973). Biochemistry, 12, p4161. 
 
Lehninger, A.L. (1975): Biochemistry, 2ed ed., Worth Publishers, New York. 
 
Mandsager, R. E., Clarke, C. R., Shawley, R. V., Hague, C. M. (1995). American  Journal of  
Veterinary Research, 56, p95. 
 
  
107 
 
Mansel Davies, M. (Ed). (1963): Infra-Red Spectroscopy and Molecular Structure. An outline 
of the principles. Elsevier, New York. 
 
Michael Hollas. J. (2004): MODERN SPECTROSCOPY. 4th Ed. John Wiley & Sons, 
Chichester, England. 
 
Muñoz-Cuevas, J., Cruz-Paz, M., Olivero-Vásquez, Y.  (2005). Revista Mexicana Anestesia, 
28, p148. 
 
Matsuura, H., Hasegawa, K., Miyazawa, T. (1986).  Spectrochim. Acta A 42, p1181. 
 
Moreno, F., Jose, J. G.(1999). Chemico-Biological Interactions 121, p237. 
 
Neault, J. F., Benkirane, A., Malonga, H., Tajmir-Riahi, H. A. (2001). Journal of Inorganic 
Biochemistry 86, p603. 
 
Nahar, S., Carpentier, R., Tajmir-Riahi, H. A. (2001).  J. Inorg. Biochem. 65, p245. 
 
Nakanishi, K. and Solomon, P. H. (1977): Infrared Spectroscopy,  Holden-Day, San Francisco. 
 
Oettl, K. and Stauber, R. E. (2007). British Journal of Pharmacology, 151, p580. 
 
Oberg, K. A., Ruysschaert, J. M., Goormaghtigh, E. (2004). Eur. J. Biochem., 271, p2937. 
 
Olinger  J. M., Hill, D. M., Jakobsen, R. J., Brody, R. S. (1986). Biochim. Biophys. Acta 869, 
p89. 
 
Owen, T. Fundamentals of modern UV-visible spectroscopy, Primer, Agilent Technologies. 
 
Purcell, M., Neault, J. F., Tajmir-Riahi, H. A. (2000). Biochim. Biophys. Acta., 1478, p61. 
 
Parker, S. F. (1983): Applications of infrared, raman, and resonance raman spectroscopy in 
biochemistry, Plenum Press, New York. 
 
Pershad, J., Wan, J., Doralina, L. (2007). Pediatrics, 120, p629. 
 
Pershad, J., Gilmore, B. (2006). Pediatrics,117, p413.  
 
Padrid, P. (2000). Vet Clin North Am, 30, p1390. 
 
Peters, T. (1995): All about albumin, Academic Press, San Diego. 
 
Peter, R. Griffiths, A., James, A. (2007):  Fourier Transform Infrared Spectrometry, 2nd ed., 
John Wiley & Sons. 
  
108 
 
Ruhl, T. et al. (2003). Bioorg. Med. Chem. 11, p2965. 
 
Robinson, J. W., Skelly, E. M., Frame,  G. M. (2005): Undergraduate Instrumental Analysis. 6th 
ed. Marcel Dekker New York. 
 
Richardson, J. S. (1981). Adv. Protein Chem., 34, p167. 
 
Rahmelow, K. and Hubner, W. (1996). Anal. Biochem., 241, p5. 
 
Reves, J.G. and Lubarsky, D.A. (2000): Nonbarbiturate intravenous anesthetics. In: R. Miller 
(Ed). Anesthesia. (251-254). 5th ed., Churchill Livingstone, Philadelphia, PA. 
 
Smith, I., White P. F., Nathanson, M., Gouldson, R. (1994). Anesthesiology, 81, p1005. 
 
Schuttler, J.,and Ihmsen, H. (2000). Anesthesia, 92, p727. 
 
Schaller, J., Gerber, S., Kämpfer, U., Lejon, S., Trachsel, C. (2008): Human Blood Plasma  
Proteins: Structure and Function,  John Wiley & Sons, 
 
Sudlow, G.,  Birkett, D. J., Wade, D. N. (1975). Mol Pharmacol 11, p824. 
 
Shin-ichi, F., Takashi, A. (2008). Biophys J, 94, p95. 
 
Simard, J. R.,  Zunszain, P. A.,  Hamilton, J. A., Curry, S. (2006): Location of High and Low 
Affinity Fatty Acid Binding Sites on Human Serum Albumin Revealed by NMR Drug-
competition , J. Mol. Biol. 361, 336-351. 
 
Susi, H. and Byler, D. M. (1983). Biophys Biochem Res Com 115, p391. 
 
Sathyanarayana. D. N. (1004): Vibrational spectroscopy :Theory and applications. 1st ed., New 
Age International (P) Ltd., New Delhi. 
 
Schermann, J. (2008): Spectroscopy and modelling of biomolecular building bloks. 1st ed., 
Elsevier, UK. 
 
Siebert, F. and Hildebrandt, P. (2008): Vibrational Spectroscopy in Life Science. WILEY-
VCH Verlag GmbH & Co. KGaA, Weinheim, Germany. 
 
Shaw, T. I., et al. (1993). Spectroscopy, 8, p45. 
 
Szudy, J. (Ed). (1998):, Uniwersytet Mikolaja Kopernika, Torun, Poland.8. Acta Physica 
Polonica. 1978. Polska Akademia Nauk Instytut Fizyki. Europhys J, Vol.A65(6). 
 
Stokes, G.G. (1852). Phil Trans R Soc. 142, p463. 
  
109 
 
Surewicz, W.K. and Mantsch, H.H. (1988). Biochim. Biophys. Acta 952, p115. 
 
Surewicz, W. K., Mantsch, H. H., Chapman, D. (1993). Biochemistry 32, p389. 
 
Stephanos, J. J.(1996).  Inorg. Biochem., 62, p155. 
 
Sulkowaska, A. (2002). J. Mol. Strurct., 614, p227. 
 
Stephanos, J. farina, S., Addison. A.(1996). Biochemica. Biophysica. Acta., 1295, p209. 
 
Sirotkin, V. A., Zinatullin, A. N., Solomonov, B. N., Faizullin, D. A., Fedotov, V. D. (2001).  
Biochimica et Biophysica Acta 1547, p359. 
 
Spectroscopic Software Reference Manual. BRUKER OPTIK GmbH, Rudolf-Plank 2004 
Ettlingen.  
 
Surewicz, W. K., Mantsch, H. H., Chapman, D. (1993). Biochemistry 32, p389. 
 
Theophanides, T. (Ed.) (1984): FT-IR Spectroscopy: Industrial Chemical and Biochemical 
Applications. Netherlands: Reidel, Dordrecht. 
 
Tian, J. N., Liu, J. Q., Zhang, J. Y., Hu, Z. D., Chen, X. G.(2003).  Chem. Pharm. Bull., 51, 
p579. 
 
Tuan, V., Chuang, G., Otagiri, M. (2001). Biochimica et Biophysica Acta, 1546, p337. 
 
Upton, R.N., Ludrook, G.I., Grant, C. (1999). Anesthesia Analgesia, 89, p545. 
 
Uversky, V. N. and. Permyakov. E. A. (2007): Vibrational Spectroscopy: Methods in Protein 
Structure and Stability Analysis. Nova Science, New York. 
 
Ulrich, K. H. Hiroshi, W., Keisuke, N. Yasunori, I., Masaki, O. (2006). J. Mol. Biol. 363, 
p702. 
 
Whitlock F.A. (1975). Med J Aust 1, 24, p737. 
 
Wright, M.  (1982). Journal of the American Veterinary Medical Association,180, p1462. 
 
Whiffen, D. H. (1972): Spectroscopy, 2nd, ongmans, London. 
 
Wetlaufer, D. (1962). Adv. Protein Chem. 17, p303. 
 
Workman, J. R. (1998): Applied Spectroscopy: Optical Spectrometers. Academic Press. 
  
110 
 
Wang, T.,  Xiang, B., Wang, Y., Chen, C., Dong, Y., Fang, H., Wang, M. (2008). Colloids 
Surf. B 65, p113. 
 
Xie, M. X., Xu, X. Y., Wang, Y. D. (2005). Biochim. Biophys. Acta 1724, p215. 
 
Yamamoto, T. and Tasumi, M. (1991). J. Mol. Struct. 242, p235. 
 
Zsila, F., Bik´adi, Z., Simonyi, M. (2003). Biochem. Pharmacol. 65, p447. 
 
Zhao, B. Z., Song, L. M., Liu, X., Xie, J., Zhao, J. Q. (2006). Bioorg. Med. Chem. 14, p2428. 
 
Zhang, W. S., Li, A. L. (1999): Medical Chemistry, Higher Education Press.  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 111
 
 الملخص
 
 mureS namuH)مع بروتين الدم البشري ( بنتوباربيتال و البروبوفول) تم دراسة التفاعل بين كل من الأدوية المخدرة 
، جهاز انبعاث ( ypocsortceps elbisiv-VU) باستخدام جهاز مطياف الأشعة فوق البنفسجية(  nimublA
 reiruoF)ويل فوريير للأشعة تحت الحمراء وجهاز مطياف تح( ypocsortceps ecnecseroulF)الاشعاع 
للبنتوباربيتال ( tnatsnoc gnidnib)  حيث تم حساب ثابت الترابط( ypocsortceps derarfnI mrofsnart
( K392)والبروبوفول عن طريف جهاز مطياف الأشعة فوق البنفسجية وجهاز مطياف انبعاث الاشعاع عند درجة حرارة 
بالإضافة الى ذلك تم حساب ثابت . للبروبوفول( 1-M 301x55.2)للبنتوباربيتال و (  1-M 401x218.1)والقيم هي 
( 1-lom L 601x686.9)و ( 1-lom L 701x578.3)وهي للبنتوباربيتال (  tnatsnoc remloV-netS)
  .للبروبوفول
لبروتين الدم ( ytisnetnI mumixaM)ومن النتائج التي تم التوصل اليها هي أن شدة امتصاص الإشعة فوق البنفسجية 
  .تزداد بزيادة تركيز هذه المواد مع بقاء تركيز البروتين ثابت( البنتوباربيتال واليروبوفول)مع الأدوية المخدرة 
الإشعاع المنبعث جراء ( ytisnetnI)ومن خلال استخدام جهاز إنبعاث الإشعاع وجد أن النتائج تكشف عن انخفاض شدة 
حيث  .مع زيادة تركيز الدوائين وبقاء تركيز البروتين ثابت( ASH)يتال والبروبوفول من بروتين الدم تفاعل كل من البنتوبارب
أن هذا الإنخفاض في شدة الإشعاع المنبعث يشير الى أن كل من البنتوباربيتال والبروبوفول لديها قدرة قوية على خفض أو 
  (. gnihcneuq citatS)من خلال الية ( ASH)التقليل من الإشعاع المنبعث ذاتياً من البروتين 
مع تطبيق عدد من التقنيات الموجود في هذا الجهاز مثل ( RITF)بإستخدام جهاز مطياف تحويل قوريير للأشعة تحت الحمراء 
بالإضافة الى تقنية ( noituloser evitavired dnoceS)و ( noitulovnoced fles-reiruoF)تقنية 
تم تحليل منطقة الأميد الاول والأميد الثاني والأميد الثالث الموجودة في بروتين الدم  (erudecorp gnittif evruC)
والية ارتباط الأدوية المخدرة معه حيث أن  (erutcurts yradnoceS)من أجل تحديد بنية البروتين الثانوية ( ASH)
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الى تحديد وتفسير التغيرات في مواقع القمم تم تحديدها في مناطق الاميد الثلاث، بالإضافة ( skaeP)جميع مواقع القمم 
  . نتيجة تغيير تركيز الأدوية المضافة( skaeP)
نتيجة تغيير في ( sdnab noitprosbA)الى تغيير في شدة حزم الامتصاص ( RITF)يشير الطيف المقاس بواسطة جهاز 
من خلال هذه النتائج أن هناك انخفاض أكبر في شدة إضافة الى ذلك ظهر (. البنتوباربيتال والبروبوفول)تركيز الأدوية المضافة 
  (.steehs-β)بالمقارنة مع حزم الامتصاص التابعة ( xileh-α )حزم الإمتصاص التابعة ل 
في ( gnidnob-H)يرجع على تكوين الروابط الهيدروجينية ( ytisnetni ehT)هذا التباين والإختلاف في الشدة 
  .لتكوين هذه الروابط( steehs-β)و ( xileh-α )لميول الذاتي لكل من  الجزيثات المعقدة، وهو ما يفسر ا
  
-)مجموعات الهيدروكسيل )و (( H-N) ومجموعات الامين( O=C)مجموعات الكاربونيل )من خلال هذا البحث وجد أن 
اً في تغيير البنية الثانوية الموجود في البناء الجزيئي لكل من البنتوباربيتال والبروبوفول على التوالي تلعب دوراً هام(( HO
ويدعم هذا التحليل تلك النتائج التي تم التوصل اليها . عند ارتباطها معه( ASH)للبروتين ( erutcurts yradnoceS)
للبروبوفول بالمقارنة من البنتوباربيتال يشير الى أن ( tnatsnoc gnidnib)حيث أن الانخفاض في قيمة ثابت الترابط 
 .تخدير في وقت أقل من البنتوباربيتال وهذا يتفق مع كل ما تم التوصل اليه مسبقاً البروبوفول يعطي
 
